Psychology and Neuroscience Faculty Database
Psychology and Neuroscience
Arts & Sciences
Duke University

 HOME > Arts & Sciences > pn > Faculty    Search Help Login pdf version printable version 

Publications of Melanie J. Bonner    :chronological  alphabetical  combined listing:

%% Journal Articles   
@article{fds371817,
   Author = {Meyer, R and Wang, K and Yearley, A and Grob, S and Zeitlin, J and Bloomfeld, J and You, M and Lee, D and Bonner, M and Shah, N and Page,
             K},
   Title = {Usability and Acceptability of the QuestLeukemia Mobile
             Application: A Pilot Study for An Educational and
             Psychological Intervention for Children with Chronic
             Illnesses.},
   Journal = {J Pediatr Hematol Oncol Nurs},
   Volume = {39},
   Number = {3},
   Pages = {137-142},
   Year = {2022},
   url = {http://dx.doi.org/10.1177/27527530221068422},
   Abstract = {It is widely accepted that educational interventions benefit
             children with chronic diseases (disease awareness and
             autonomy) or those undergoing medical procedures (decreased
             anxiety and improved satisfaction). Hematopoietic cell
             transplantation (HCT) is an intensive procedure to treat
             life-threatening diseases but is associated with multiple
             adverse medical experiences. QuestLeukemia (QuestED, Durham,
             NC) is a mobile app designed to educate pediatric patients
             preparing for HCT through age-appropriate videos and
             quizzes. Here we describe the results of the initial pilot
             study assessing acceptability and feasibility of
             QuestLeukemia app. Eligible participants were selected from
             a convenience sample (inpatient HCT unit and outpatient
             clinic). Participants spent 30-60 min using the app then
             completed a survey assessing the app for usability,
             accessibility, and user satisfaction. Participants
             identified the app as a useful tool for gaining
             disease-related knowledge and reported greater autonomy over
             their disease process. On average, patients indicated that
             the app was easy to use (M = 4.93), enjoyable (M = 4.79),
             and comprehensive (M = 4.71). Parents followed similar
             trends of satisfaction with the app. Pediatric HCT providers
             likewise reported that the app was easy to use (M = 4.22),
             enjoyable (M = 4.85), and educationally comprehensive (M =
             4.77). The QuestLeukemia mobile application prototype
             provides an easy, enjoyable, and educational tool for
             pediatric patients undergoing HCT. This application was well
             received by patients, parents, and providers. These findings
             will be used to design future iterations of the game in
             clinical care.},
   Doi = {10.1177/27527530221068422},
   Key = {fds371817}
}

@article{fds358052,
   Author = {Moya-Mendez, ME and Mueller, DM and Pratt, M and Bonner, M and Elliott,
             C and Hunanyan, A and Kucera, G and Bock, C and Prange, L and Jasien, J and Keough, K and Shashi, V and McDonald, M and Mikati,
             MA},
   Title = {Early onset severe ATP1A2 epileptic encephalopathy: Clinical
             characteristics and underlying mutations.},
   Journal = {Epilepsy Behav},
   Volume = {116},
   Pages = {107732},
   Year = {2021},
   Month = {March},
   url = {http://dx.doi.org/10.1016/j.yebeh.2020.107732},
   Abstract = {BACKGROUND: ATP1A2 mutations cause hemiplegic migraine with
             or without epilepsy or acute reversible encephalopathy.
             Typical onset is in adulthood or older childhood without
             subsequent severe long-term developmental impairments. AIM:
             We aimed to describe the manifestations of early onset
             severe ATP1A2-related epileptic encephalopathy and its
             underlying mutations in a cohort of seven patients. METHODS:
             A retrospective chart review of a cohort of seven patients
             was conducted. Response to open-label memantine therapy,
             used off-label due to its NMDA receptor antagonist effects,
             was assessed by the Global Rating Scale of Change (GRSC) and
             Clinical Global Impression Scale of Improvement (CGI-I)
             methodologies. Molecular modeling was performed using PyMol
             program. RESULTS: Patients (age 2.5-20 years) had symptom
             onset at an early age (6 days-1 year). Seizures were
             either focal or generalized. Common features were: drug
             resistance, recurrent status epilepticus, etc., severe
             developmental delay with episodes of acute severe
             encephalopathy often with headaches, dystonias, hemiplegias,
             seizures, and developmental regression. All had variants
             predicted to be disease causing (p.Ile293Met, p.Glu1000Lys,
             c.1017+5G>A, p.Leu809Arg, and 3 patients with p.Met813Lys).
             Modeling revealed that mutations interfered with ATP1A2 ion
             binding and translocation sites. Memantine, given to five,
             was tolerated in all (mean treatment: 2.3 years, range
             6 weeks-4.8 years) with some improvements reported in
             all five. CONCLUSIONS: Our observations describe a
             distinctive clinical profile of seven unrelated probands
             with early onset severe ATP1A2-related epileptic
             encephalopathy, provide insights into structure-function
             relationships of ATP1A2 mutations, and support further
             studies of NMDAR antagonist therapy in ATP1A2-encephalopathy.},
   Doi = {10.1016/j.yebeh.2020.107732},
   Key = {fds358052}
}

@article{fds352041,
   Author = {Wallace, K and Uchitel, J and Prange, L and Jasien, J and Bonner, M and D'Alli, R and Maslow, G and Mikati, MA},
   Title = {Characterization of Severe and Extreme Behavioral Problems
             in Patients With Alternating Hemiplegia of
             Childhood.},
   Journal = {Pediatr Neurol},
   Volume = {111},
   Pages = {5-12},
   Year = {2020},
   Month = {October},
   url = {http://dx.doi.org/10.1016/j.pediatrneurol.2020.06.012},
   Abstract = {BACKGROUND: Alternating hemiplegia of childhood often
             manifests severe or extreme behavioral problems, the nature
             of which remains to be fully characterized. METHODS: We
             analyzed 39 consecutive patients with alternating hemiplegia
             of childhood for occurrence of behavioral problems and
             categorized those by severity: mild (not requiring
             intervention), moderate (requiring intervention but no
             risk), severe (minor risk to self, others, or both), and
             extreme (major risk). We then analyzed behavioral
             manifestations, concurrent morbidity, and medication
             responses in patients with severe or extreme symptoms.
             RESULTS: Two patients had mild behavioral problems, five
             moderate, 10 severe, six extreme, and 16 none. Extreme cases
             exhibited disruptive behaviors escalating to assaults.
             Triggers, when present, included peer-provocation, low
             frustration tolerance, limits set by others, and sleep
             disruption. Reversible psychotic symptoms occurred in two
             patients: in one triggered by infection and trihexyphenidyl,
             and in another triggered by sertraline. Of the 16 patients
             with severe or extreme symptoms, 13 had concurrent
             neuropsychiatric diagnoses. Occurrence of severe or extreme
             symptoms did not correlate with age, puberty, severity of
             intellectual disability, or mutation status (P > 0.05). A
             multidisciplinary team including mental health professionals
             comanaged all patients with severe or extreme symptoms with
             either behavioral therapy, medications, or both. When
             considering medications prescribed to more than four
             patients, medicines that demonstrated efficacy or partial
             efficacy in more than 50% of patients were alpha-adrenergic
             agonists and selective-serotonin-reuptake-inhibitors.
             CONCLUSIONS: Patients with alternating hemiplegia of
             childhood (41%) often experience severe or extreme
             behavioral problems and, rarely, medication-triggered
             psychotic symptoms. These observations are consistent with
             current understanding of underlying alternating hemiplegia
             of childhood brain pathophysiology. Increasing awareness of
             these behavioral problems facilitates alternating hemiplegia
             of childhood management and anticipatory
             guidance.},
   Doi = {10.1016/j.pediatrneurol.2020.06.012},
   Key = {fds352041}
}

@article{fds348709,
   Author = {Uchitel, J and Abdelnour, E and Boggs, A and Prange, L and Pratt, M and Bonner, M and Jasien, J and Dawson, G and Abrahamsen, T and Mikati,
             MA},
   Title = {Social impairments in alternating hemiplegia of
             childhood.},
   Journal = {Dev Med Child Neurol},
   Volume = {62},
   Number = {7},
   Pages = {820-826},
   Year = {2020},
   Month = {July},
   url = {http://dx.doi.org/10.1111/dmcn.14473},
   Abstract = {AIM: To evaluate presence and severity of social impairments
             in alternating hemiplegia of childhood (AHC) and determine
             factors that are associated with social impairments. METHOD:
             This was a retrospective analysis of 34 consecutive patients
             with AHC (19 females, 15 males; mean age: 9y 7mo, SD 8y 2mo,
             range 2y 7mo-40y), evaluated with the Social Responsiveness
             Scale, Second Edition (SRS-2). RESULTS: SRS-2 scores,
             indicating level of social impairment, were higher than
             population means (75, SD 14 vs 50, SD 10, p<0.001). Of
             these, 27 out of 34 had high scores: 23 severe (>76), four
             moderate (66-76). All subscale domains, including social
             cognition, social communication, social awareness, social
             motivation, restricted interests, and repetitive behavior,
             had abnormal scores compared to population means (p<0.001).
             High SRS-2 scores were associated with the presence of
             autism spectrum disorder (ASD) and epilepsy (p=0.01,
             p=0.04), but not with other scales of AHC disease
             symptomatology. All nine patients who received formal
             evaluations for ASD, because they had high SRS-2 scores,
             were diagnosed with ASD. INTERPRETATION: Most patients with
             AHC have impaired social skills involving multiple domains.
             ASD is not uncommon. High SRS-2 scores in patients with AHC
             support referral to ASD evaluation. Our findings are
             consistent with current understandings of the
             pathophysiology of AHC and ASD, both thought to involve
             GABAergic dysfunction. WHAT THIS PAPER ADDS: Most patients
             with alternating hemiplegia of childhood (AHC) have impaired
             social skills involving multiple domains. These impairments
             are significant compared to population means. Most patients
             with AHC have high Social Responsiveness Scale, Second
             Edition (SRS-2) scores. Patients with AHC with high SRS-2
             scores are likely to have autism spectrum
             disorder.},
   Doi = {10.1111/dmcn.14473},
   Key = {fds348709}
}

@article{fds349714,
   Author = {Kuerten, BG and Brotkin, S and Bonner, MJ and Ayuku, DO and Njuguna, F and Taylor, SM and Puffer, ES},
   Title = {Psychosocial Burden of Childhood Sickle Cell Disease on
             Caregivers in Kenya.},
   Journal = {Journal of pediatric psychology},
   Volume = {45},
   Number = {5},
   Pages = {561-572},
   Year = {2020},
   Month = {June},
   url = {http://dx.doi.org/10.1093/jpepsy/jsaa021},
   Abstract = {<h4>Objectives</h4>To characterize the types and magnitude
             of psychosocial burden present in caregivers who have a
             child with sickle cell disease (SCD) in Kenya and to
             identify predictors of caregiver psychosocial burden,
             including disease severity and financial
             hardship.<h4>Methods</h4>Primary caregivers (N = 103) of
             children aged 1-10 years diagnosed with SCD completed
             surveys assessing multiple domains of caregiver quality of
             life (QOL), adjustment to child illness, mental health, and
             financial hardship. Descriptive statistics characterize
             psychosocial burden, and linear models assess
             associations.<h4>Results</h4>On indicators of QOL,
             caregivers report multiple difficulties across most domains,
             including daily activities and physical, social, cognitive,
             and emotional well-being. Daily activities emerged as most
             burdensome. On indicators of parental adjustment to chronic
             illness, guilt and worry emerged as the greatest concern,
             followed by long-term uncertainty and unresolved sorrow and
             anger; relative to these, they reported higher levels of
             emotional resources. Financial hardship was high, as
             caregivers reported moderate to major financial losses due
             to the time spent caring for their child. General linear
             model analyses revealed that level of financial hardship was
             a significant predictor of all negative psychosocial
             outcomes.<h4>Conclusions</h4>Results document that Kenyan
             caregivers of children with SCD experience difficulties
             across multiple domains of functioning and that financial
             difficulties are likely associated with psychosocial burden.
             Results can guide intervention development for caregivers of
             children with SCD in low-resource, global
             contexts.},
   Doi = {10.1093/jpepsy/jsaa021},
   Key = {fds349714}
}

@article{fds347675,
   Author = {Allen, TM and Anderson, LM and Brotkin, SM and Rothman, JA and Bonner,
             MJ},
   Title = {Computerized cognitive training in pediatric sickle cell
             disease: A randomized controlled pilot study.},
   Journal = {Clinical Practice in Pediatric Psychology},
   Volume = {8},
   Number = {4},
   Pages = {390-401},
   Year = {2020},
   Month = {January},
   url = {http://dx.doi.org/10.1037/cpp0000313},
   Abstract = {Objective: The current study assessed the feasibility of a
             computerized cognitive intervention, Cogmed, in a sample of
             youth with SCD (ages 8–16 years). If deemed feasible, the
             secondary aim of the study was to evaluate preliminary
             efficacy. Methods: Youth with SCD were randomized to a
             waitlist control or the Cogmed program. Data pertaining to
             cognitive functioning, psychosocial functioning, and disease
             characteristics were obtained from participants pre- and
             postintervention. In addition, data regarding participant
             interest, consent rate, and intervention compliance were
             tracked. Results: Eighteen participants (M = 12.2 years old)
             enrolled in this study. Results indicate that the majority
             of prospective families approached about the intervention
             (82%) expressed interest in participating in the study,
             although less than 25% of interested participants enrolled.
             Three of 18 consenting participants completed the
             intervention. Cognitive, medical, and psychosocial factors
             related to feasibility and compliance were identified.
             Conclusions: Taken together, the results of this study
             suggest that there is a high degree of interest for this
             type of intervention but poor feasibility in practice.
             Implications and future directions are discussed. (PsycInfo
             Database Record (c) 2020 APA, all rights
             reserved)Implications for Impact Statement: Children with
             sickle cell disease (SCD) have a high risk of neurocognitive
             impairment, for which there are no interventions supported
             by research. While the computerized, game-like treatment
             “Cogmed” has been successfully used with other groups,
             the current study demonstrated very limited tolerability in
             youth with SCD. Thus, additional efforts are needed to
             innovate new cognitive therapies for this unique and in need
             population of children. (PsycInfo Database Record (c) 2020
             APA, all rights reserved)},
   Doi = {10.1037/cpp0000313},
   Key = {fds347675}
}

@article{fds346779,
   Author = {Brotkin, SM and Maslow, GR and Bonner, MJ},
   Title = {JPP Student Journal Club Commentary: The Relationship
             between Parent and Child Distress in Pediatric
             Cancer.},
   Journal = {J Pediatr Psychol},
   Volume = {44},
   Number = {10},
   Pages = {1137-1139},
   Year = {2019},
   Month = {November},
   url = {http://dx.doi.org/10.1093/jpepsy/jsz080},
   Doi = {10.1093/jpepsy/jsz080},
   Key = {fds346779}
}

@article{fds344882,
   Author = {Olivier, TW and Bass, JK and Ashford, JM and Beaulieu, R and Scott, SM and Schreiber, JE and Palmer, S and Mabbott, DJ and Swain, MA and Bonner, M and Boyle, R and Chapeiski, ML and Evankovich, KD and Armstrong, CL and Knight, SJ and Wu, S and Onar-Thomas, A and Gajjar, A and Conklin,
             HM},
   Title = {Cognitive Implications of Ototoxicity in Pediatric Patients
             With Embryonal Brain Tumors.},
   Journal = {J Clin Oncol},
   Volume = {37},
   Number = {18},
   Pages = {1566-1575},
   Year = {2019},
   Month = {June},
   url = {http://dx.doi.org/10.1200/JCO.18.01358},
   Abstract = {PURPOSE: Sensorineural hearing loss (SNHL) is associated
             with intellectual and academic declines in children treated
             for embryonal brain tumors. This study expands upon existing
             research by examining core neurocognitive processes that may
             result in reading difficulties in children with
             treatment-related ototoxicity. PATIENTS AND METHODS:
             Prospectively gathered, serial, neuropsychological and
             audiology data for 260 children and young adults age 3 to 21
             years (mean, 9.15 years) enrolled in a multisite research
             and treatment protocol, which included surgery, risk-adapted
             craniospinal irradiation (average risk, n = 186; high risk,
             n = 74), and chemotherapy, were analyzed using linear mixed
             models. Participants were assessed at baseline and up to 5
             years after diagnosis and grouped according to degree of
             SNHL. Included were 196 children with intact hearing or mild
             to moderate SNHL (Chang grade 0, 1a, 1b, or 2a) and 64
             children with severe SNHL (Chang grade 2b or greater).
             Performance on eight neurocognitive variables targeting
             reading outcomes (eg, phonemics, fluency, comprehension) and
             contributory cognitive processes (eg, working memory,
             processing speed) was analyzed. RESULTS: Participants with
             severe SNHL performed significantly worse on all variables
             compared with children with normal or mild to moderate SNHL
             (P ≤ .05), except for tasks assessing awareness of sounds
             and working memory. Controlling for age at diagnosis and
             risk-adapted craniospinal irradiation dose, performance on
             the following four variables remained significantly lower
             for children with severe SNHL: phonemic skills, phonetic
             decoding, reading comprehension, and speed of information
             processing (P ≤ .05). CONCLUSION: Children with severe
             SNHL exhibit greater reading difficulties over time.
             Specifically, they seem to struggle most with phonological
             skills and processing speed, which affect higher level
             skills such as reading comprehension.},
   Doi = {10.1200/JCO.18.01358},
   Key = {fds344882}
}

@article{fds343762,
   Author = {Porter, LS and Baucom, DH and Bonner, M and Linardic, C and Kazak,
             AE},
   Title = {Parenting a child with cancer: a couple-based
             approach.},
   Journal = {Transl Behav Med},
   Volume = {9},
   Number = {3},
   Pages = {504-513},
   Year = {2019},
   Month = {May},
   url = {http://dx.doi.org/10.1093/tbm/ibz016},
   Abstract = {Couples co-parenting a child with cancer face significant
             stressors that can adversely affect their couple
             relationship. How parents respond as a couple may affect the
             psychological adjustment of each parent and the child, as
             well as the ability of the family to cope with the child's
             illness. The purpose of this study was to assess the
             feasibility and acceptability of a couple-based intervention
             for parents of children with cancer. We conducted a
             randomized pilot intervention study (N = 21 couples
             randomized with a 2:1 allocation to the couple-based
             intervention or education control) testing a six-session,
             telephone-based intervention that trained couples in
             relationship skills to help them care for their child,
             strengthen their relationship, and support each other. We
             examined feasibility and acceptability of the intervention
             to the parents. In this study, 56% of eligible couples
             agreed to participate; 82% of randomized couples completed
             post-intervention surveys, and 62% completed all six
             sessions. Satisfaction with the intervention was high (mean
             = 3.3 on a 4-point scale). Changes in both groups were small
             in magnitude and mixed in direction, with some outcomes
             favoring the couple-based intervention and other favoring
             the education condition. Supporting couples is important to
             optimize individual and parental functioning when a child
             has cancer. However, there are significant challenges to
             delivering couple-based interventions to these parents. More
             research is needed to establish optimal timing and content
             of couple-based interventions for these parents as well as
             feasible methods of delivery.},
   Doi = {10.1093/tbm/ibz016},
   Key = {fds343762}
}

@article{fds339603,
   Author = {Jasien, JM and Bonner, M and D'alli, R and Prange, L and Mclean, M and Sachdev, M and Uchitel, J and Ricano, J and Smith, B and Mikati,
             MA},
   Title = {Cognitive, adaptive, and behavioral profiles and management
             of alternating hemiplegia of childhood.},
   Journal = {Dev Med Child Neurol},
   Volume = {61},
   Number = {5},
   Pages = {547-554},
   Year = {2019},
   Month = {May},
   url = {http://dx.doi.org/10.1111/dmcn.14077},
   Abstract = {AIM: To determine the neuropsychological abnormalities that
             occur in alternating hemiplegia of childhood (AHC) and
             report on our experience in managing them. METHOD: Patients
             underwent evaluations according to our standardized AHC
             pathway. Data were entered into our prospective AHC database
             and then analyzed. RESULTS: Of the cohort of 25 consecutive
             patients (ages 15mo-42y), eight had initial chief complaints
             about cognition, 14 language, five attention, and 11
             behavior. As compared to population norms means,
             neuropsychological and behavioral assessment tools
             (including Child Behavior Checklist, Vineland Adaptive
             Behavior Scales, Peabody Picture Vocabulary, and Wechsler
             Intelligence Quotient tests) showed significant impairments
             in multiple domains: cognition, expressive and receptive
             language, executive function/attention, and behavior (p<0.05
             in all comparisons). Evaluations generated management
             recommendations in all patients. Twenty had neuropsychiatric
             diagnoses: 10 attention-deficit/hyperactivity disorder
             (ADHD), seven disruptive behavior, and three anxiety
             disorder. Eight out of nine patients with ADHD who were
             prescribed medications responded to pharmacotherapy.
             INTERPRETATION: Patients with AHC have developmental
             difficulties related to impairments in multiple
             neuropsychological domains. This supports the hypothesis
             that the underlying AHC pathophysiology involves diffuse
             neuronal dysfunction. Testing generated recommendations to
             help manage these difficulties. Patients with AHC also have
             a range of neuropsychiatric diagnoses, the most common being
             ADHD which responds to pharmacotherapy. WHAT THIS PAPER
             ADDS: Patients with alternating hemiplegia of childhood
             (AHC) have developmental difficulties with underlying
             neuropsychological impairments. The findings in this study
             are consistent with an underlying AHC pathophysiology which
             involves diffuse neuronal, probably largely GABAergic,
             dysfunction. Patients with AHC have a range of
             neuropsychiatric diagnoses, the most common being
             attention-deficit/hyperactivity disorder.},
   Doi = {10.1111/dmcn.14077},
   Key = {fds339603}
}

@article{fds338616,
   Author = {Tan, QK-G and Cope, H and Spillmann, RC and Stong, N and Jiang, Y-H and McDonald, MT and Rothman, JA and Butler, MW and Frush, DP and Lachman,
             RS and Lee, B and Bacino, CA and Bonner, MJ and McCall, CM and Pendse, AA and Walley, N and Undiagnosed Diseases Network, and Shashi, V and Pena,
             LDM},
   Title = {Further evidence for the involvement of EFL1 in a
             Shwachman-Diamond-like syndrome and expansion of the
             phenotypic features.},
   Journal = {Cold Spring Harb Mol Case Stud},
   Volume = {4},
   Number = {5},
   Year = {2018},
   Month = {October},
   url = {http://dx.doi.org/10.1101/mcs.a003046},
   Abstract = {Recent evidence has implicated EFL1 in a phenotype
             overlapping Shwachman-Diamond syndrome (SDS), with the
             functional interplay between EFL1 and the previously known
             causative gene SBDS accounting for the similarity in
             clinical features. Relatively little is known about the
             phenotypes associated with pathogenic variants in the EFL1
             gene, but the initial indication was that phenotypes may be
             more severe, when compared with SDS. We report a pediatric
             patient who presented with a metaphyseal dysplasia and was
             found to have biallelic variants in EFL1 on reanalysis of
             trio whole-exome sequencing data. The variant had not been
             initially reported because of the research laboratory's
             focus on de novo variants. Subsequent phenotyping revealed
             variability in her manifestations. Although her metaphyseal
             abnormalities were more severe than in the original reported
             cohort with EFL1 variants, the bone marrow abnormalities
             were generally mild, and there was equivocal evidence for
             pancreatic insufficiency. Despite the limited number of
             reported patients, variants in EFL1 appear to cause a
             broader spectrum of symptoms that overlap with those seen in
             SDS. Our report adds to the evidence of EFL1 being
             associated with an SDS-like phenotype and provides
             information adding to our understanding of the phenotypic
             variability of this disorder. Our report also highlights the
             value of exome data reanalysis when a diagnosis is not
             initially apparent.},
   Doi = {10.1101/mcs.a003046},
   Key = {fds338616}
}

@article{fds336054,
   Author = {Anderson, LM and Leonard, S and Jonassaint, J and Lunyera, J and Bonner,
             M and Shah, N},
   Title = {Mobile health intervention for youth with sickle cell
             disease: Impact on adherence, disease knowledge, and quality
             of life.},
   Journal = {Pediatr Blood Cancer},
   Volume = {65},
   Number = {8},
   Pages = {e27081},
   Publisher = {WILEY},
   Year = {2018},
   Month = {August},
   url = {http://dx.doi.org/10.1002/pbc.27081},
   Abstract = {BACKGROUND: Adherence to illness self-management among youth
             with sickle cell disease (SCD) positively impacts health
             outcomes and decreases overall healthcare costs. Despite
             this, children with SCD face several barriers to adherence,
             with adherence rates that remain moderate to low. The
             current feasibility study examined the Intensive Training
             Program (ITP), a mobile health (mHealth) intervention for
             youth with SCD designed to promote disease knowledge,
             adherence, and patient-provider communication. PROCEDURE:
             Youth with SCD prescribed hydroxyurea between ages 7-18
             completed baseline disease knowledge and psychosocial
             assessments and then were provided with the ITP app. Youth
             participated in the 90-day ITP, during which they completed
             three education modules, tracked adherence through daily
             self-recorded videos on the app, and received video messages
             from providers. Participants completed poststudy knowledge,
             psychosocial, and feasibility questionnaires. Medication
             possession ratio (MPR) was obtained via pharmacy-refill
             rates. RESULTS: Thirty-two youths (mean age = 13.0 years)
             participated, with an average adherence tracking rate of 0.6
             (standard deviation = 0.34). All participants demonstrated
             increased MPR (0.57-0.74, P < 0.001, d = 0.75) and
             disease knowledge (59.6-88.6%, P < 0.001). There was
             variable engagement in the ITP; completers demonstrated
             significantly better SCD-related functioning (P < 0.05),
             higher parent-reported treatment functioning (P < 0.05),
             and lower pain impact than noncompleters of the ITP
             (P < 0.05). CONCLUSIONS: Results support the ITP can
             feasibly be implemented to promote adherence among youth
             with SCD. All participants demonstrated increased adherence
             and disease knowledge. However, there was variable
             engagement and only intervention completers showed
             improvements in psychosocial outcomes. Further research is
             needed to evaluate long-term outcomes and ways to promote
             engagement in mHealth interventions among the
             youth.},
   Doi = {10.1002/pbc.27081},
   Key = {fds336054}
}

@article{fds330040,
   Author = {Schreiber, JE and Palmer, SL and Conklin, HM and Mabbott, DJ and Swain,
             MA and Bonner, MJ and Chapieski, ML and Huang, L and Zhang, H and Gajjar,
             A},
   Title = {Posterior fossa syndrome and long-term neuropsychological
             outcomes among children treated for medulloblastoma on a
             multi-institutional, prospective study.},
   Journal = {Neuro Oncol},
   Volume = {19},
   Number = {12},
   Pages = {1673-1682},
   Year = {2017},
   Month = {November},
   url = {http://dx.doi.org/10.1093/neuonc/nox135},
   Abstract = {BACKGROUND: Patients treated for medulloblastoma who
             experience posterior fossa syndrome (PFS) demonstrate
             increased risk for neurocognitive impairment at one year
             post diagnosis. The aim of the study was to examine
             longitudinal trajectories of neuropsychological outcomes in
             patients who experienced PFS compared with patients who did
             not. METHODS: Participants were 36 patients (22 males) who
             experienced PFS and 36 comparison patients (21 males) who
             were matched on age at diagnosis and treatment exposure but
             did not experience PFS. All patients underwent serial
             evaluation of neurocognitive functioning spanning 1 to 5
             years post diagnosis. RESULTS: The PFS group demonstrated
             lower estimated mean scores at 1, 3, and 5 years post
             diagnosis on measures of general intellectual ability,
             processing speed, broad attention, working memory, and
             spatial relations compared with the non-PFS group. The PFS
             group exhibited estimated mean scores that were at least one
             standard deviation below the mean for intellectual ability,
             processing speed, and broad attention across all time points
             and for working memory by 5 years post diagnosis. Processing
             speed was stable over time. Attention and working memory
             declined over time. Despite some change over time, caregiver
             ratings of executive function and behavior problem symptoms
             remained within the average range. CONCLUSION: Compared with
             patients who do not experience PFS, patients who experience
             PFS exhibit greater neurocognitive impairment, show little
             recovery over time, and decline further in some domains.
             Findings highlight the particularly high risk for long-term
             neurocognitive problems in patients who experience PFS and
             the need for close follow-up and intervention.},
   Doi = {10.1093/neuonc/nox135},
   Key = {fds330040}
}

@article{fds319600,
   Author = {Allen, TM and Anderson, LM and Rothman, JA and Bonner,
             MJ},
   Title = {[Formula: see text]Executive functioning and health-related
             quality of life in pediatric sickle cell
             disease.},
   Journal = {Child Neuropsychol},
   Volume = {23},
   Number = {8},
   Pages = {889-906},
   Year = {2017},
   Month = {November},
   url = {http://dx.doi.org/10.1080/09297049.2016.1205011},
   Abstract = {Research consistently indicates that children with sickle
             cell disease (SCD) face multiple risk factors for
             neurocognitive impairment. Despite this, no empirical
             research to date has examined the impact of neurocognitive
             functioning on quality of life for this pediatric group.
             Thus, the current study aims to examine the relationship
             between executive functioning and quality of life in a
             sample of children with SCD and further explore psychosocial
             and family/caregiver resources as moderators of this
             relationship. A total of 45 children with SCD aged 8 to 16
             years and their caregivers completed measures of quality of
             life, behavioral ratings of executive functioning, and
             psychosocial functioning. Hierarchical linear regression
             models were utilized to determine the impact of executive
             functioning on quality of life and further test the
             interaction effects of proposed moderating variables.
             Controlling for age, pain, and socioeconomic status (SES),
             executive functioning was found to significantly predict
             child- and parent-reported quality of life among youth with
             SCD. Psychosocial resources of the primary caregiver or
             family was not found to moderate the relationship between
             executive functioning and quality of life. These results
             provide the first empirical evidence that lower executive
             skills negatively predict quality of life for children with
             SCD, supporting clinical and research efforts which aim to
             establish efficacious interventions that target cognitive
             decrements within this pediatric population.},
   Doi = {10.1080/09297049.2016.1205011},
   Key = {fds319600}
}

@article{fds330041,
   Author = {Gallentine, WB and Shinnar, S and Hesdorffer, DC and Epstein, L and Nordli, DR and Lewis, DV and Frank, LM and Seinfeld, S and Shinnar, RC and Cornett, K and Liu, B and Moshé, SL and Sun, S and FEBSTAT Investigator
             Team},
   Title = {Plasma cytokines associated with febrile status epilepticus
             in children: A potential biomarker for acute hippocampal
             injury.},
   Journal = {Epilepsia},
   Volume = {58},
   Number = {6},
   Pages = {1102-1111},
   Year = {2017},
   Month = {June},
   url = {http://dx.doi.org/10.1111/epi.13750},
   Abstract = {OBJECTIVE: Our aim was to explore the association between
             plasma cytokines and febrile status epilepticus (FSE) in
             children, as well as their potential as biomarkers of acute
             hippocampal injury. METHODS: Analysis was performed on
             residual samples of children with FSE (n = 33) as part of
             the Consequences of Prolonged Febrile Seizures in Childhood
             study (FEBSTAT) and compared to children with fever
             (n = 17). Magnetic resonance imaging (MRI) was obtained as
             part of FEBSTAT within 72 h of FSE. Cytokine levels and
             ratios of antiinflammatory versus proinflammatory cytokines
             in children with and without hippocampal T2 hyperintensity
             were assessed as biomarkers of acute hippocampal injury
             after FSE. RESULTS: Levels of interleukin (IL)-8 and
             epidermal growth factor (EGF) were significantly elevated
             after FSE in comparison to controls. IL-1β levels trended
             higher and IL-1RA trended lower following FSE, but did not
             reach statistical significance. Children with FSE were found
             to have significantly lower ratios of IL-1RA/IL-1β and
             IL-1RA/IL-8. Specific levels of any one individual cytokine
             were not associated with FSE. However, lower ratios of
             IL-1RA/IL-1β, IL-1RA/1L-6, and IL-1RA/ IL-8 were all
             associated with FSE. IL-6 and IL-8 levels were significantly
             higher and ratios of IL-1RA/IL-6 and IL-1RA/IL-8 were
             significantly lower in children with T2 hippocampal
             hyperintensity on MRI after FSE in comparison to those
             without hippocampal signal abnormalities. Neither individual
             cytokine levels nor ratios of IL-1RA/IL-1β or IL-1RA/IL-8
             were predictive of MRI changes. However, a lower ratio of
             IL-1RA/IL-6 was strongly predictive (odds ratio [OR] 21.5,
             95% confidence interval [CI] 1.17-393) of hippocampal T2
             hyperintensity after FSE. SIGNIFICANCE: Our data support
             involvement of the IL-1 cytokine system, IL-6, and IL-8 in
             FSE in children. The identification of the IL-1RA/IL-6 ratio
             as a potential biomarker of acute hippocampal injury
             following FSE is the most significant finding. If replicated
             in another study, the IL-1RA/IL-6 ratio could represent a
             serologic biomarker that offers rapid identification of
             patients at risk for ultimately developing mesial temporal
             lobe epilepsy (MTLE).},
   Doi = {10.1111/epi.13750},
   Key = {fds330041}
}

@article{fds316069,
   Author = {Willard, VW and Allen, TM and Hardy, KK and Bonner,
             MJ},
   Title = {Social functioning in survivors of pediatric brain tumors:
             Contribution of neurocognitive and social-cognitive
             skills},
   Journal = {Children's Health Care},
   Volume = {46},
   Number = {2},
   Pages = {181-195},
   Publisher = {Informa UK Limited},
   Year = {2017},
   Month = {April},
   ISSN = {0273-9615},
   url = {http://dx.doi.org/10.1080/02739615.2015.1124769},
   Abstract = {This study assessed neurocognitive and social-cognitive
             skills in survivors of pediatric brain tumors, and evaluated
             their combined contribution to social outcomes. Survivors
             (N = 10) and typically developing children (N = 41),
             aged 8–16, completed measures of neurocognitive and
             social-cognitive skills, and social functioning/adjustment.
             Survivors demonstrated difficulties across domains as
             compared to typically developing children. Hierarchical
             regression analyses with the combined sample suggested that
             the combination of neurocognitive and social-cognitive
             skills accounted for over half of the variance in
             parent-reported social functioning. Inattentive symptoms and
             recognition of child faces were significantly associated
             with social outcomes. Increasing our understanding of social
             outcomes in survivors is critical to the creation of
             targeted interventions.},
   Doi = {10.1080/02739615.2015.1124769},
   Key = {fds316069}
}

@article{fds324821,
   Author = {Shashi, V and Pena, LDM and Kim, K and Burton, B and Hempel, M and Schoch,
             K and Walkiewicz, M and McLaughlin, HM and Cho, M and Stong, N and Hickey,
             SE and Shuss, CM and Undiagnosed Diseases Network, and Freemark, MS and Bellet, JS and Keels, MA and Bonner, MJ and El-Dairi, M and Butler, M and Kranz, PG and Stumpel, CTRM and Klinkenberg, S and Oberndorff, K and Alawi, M and Santer, R and Petrovski, S and Kuismin, O and Korpi-Heikkilä, S and Pietilainen, O and Aarno, P and Kurki, MI and Hoischen, A and Need, AC and Goldstein, DB and Kortüm,
             F},
   Title = {De Novo Truncating Variants in ASXL2 Are Associated with a
             Unique and Recognizable Clinical Phenotype.},
   Journal = {Am J Hum Genet},
   Volume = {100},
   Number = {1},
   Pages = {179},
   Year = {2017},
   Month = {January},
   url = {http://dx.doi.org/10.1016/j.ajhg.2016.12.004},
   Doi = {10.1016/j.ajhg.2016.12.004},
   Key = {fds324821}
}

@article{fds330042,
   Author = {Weiss, EF and Masur, D and Shinnar, S and Hesdorffer, DC and Hinton, VJ and Bonner, M and Rinaldi, J and Van de Water and V and Culbert, J and Shinnar,
             RC and Seinfeld, S and Gallentine, W and Nordli, DR and Frank, LM and Epstein, L and Moshé, SL and Sun, S and FEBSTAT study
             team},
   Title = {Cognitive functioning one month and one year following
             febrile status epilepticus.},
   Journal = {Epilepsy Behav},
   Volume = {64},
   Number = {Pt A},
   Pages = {283-288},
   Year = {2016},
   Month = {November},
   url = {http://dx.doi.org/10.1016/j.yebeh.2016.09.013},
   Abstract = {OBJECTIVE: The objective of this study was to determine
             early developmental and cognitive outcomes of children with
             febrile status epilepticus (FSE) one month and one year
             after FSE. METHODS: One hundred ninety four children with
             FSE were evaluated on measures of cognition, receptive
             language, and memory as part of the FEBSTAT study and
             compared with 100 controls with simple febrile seizures
             (FSs). RESULTS: Children with FSE did not differ
             dramatically on tasks compared with FS controls at one month
             after FSE but demonstrated slightly weaker motor development
             (p=0.035) and receptive language (p=0.034) at one year after
             FSE. Performances were generally within the low average to
             average range. Within the FSE cohort, non-White children
             performed weaker on many of the tasks compared with
             Caucasian children. At the one-year visit, acute hippocampal
             T2 findings on MRI were associated with weaker receptive
             language skills (p=0.0009), and human herpes virus 6 or 7
             (HHV6/7) viremia was associated with better memory
             performances (p=0.047). CONCLUSION: Febrile status
             epilepticus does not appear to be associated with
             significant cognitive impairment on early developmental
             measures, although there is a trend for possible receptive
             language and motor delay one year after FSE. Further
             follow-up, which is in progress, is necessary to track
             long-term cognitive functioning.},
   Doi = {10.1016/j.yebeh.2016.09.013},
   Key = {fds330042}
}

@article{fds319599,
   Author = {Shashi, V and Pena, LDM and Kim, K and Burton, B and Hempel, M and Schoch,
             K and Walkiewicz, M and McLaughlin, HM and Cho, M and Stong, N and Hickey,
             SE and Shuss, CM and Undiagnosed Diseases Network, and Freemark, MS and Bellet, JS and Keels, MA and Bonner, MJ and El-Dairi, M and Butler, M and Kranz, PG and Stumpel, CTRM and Klinkenberg, S and Oberndorff, K and Alawi, M and Santer, R and Petrovski, S and Kuismin, O and Korpi-Heikkilä, S and Pietilainen, O and Aarno, P and Kurki, MI and Hoischen, A and Need, AC and Goldstein, DB and Kortüm,
             F},
   Title = {De Novo Truncating Variants in ASXL2 Are Associated with a
             Unique and Recognizable Clinical Phenotype.},
   Journal = {Am J Hum Genet},
   Volume = {99},
   Number = {4},
   Pages = {991-999},
   Year = {2016},
   Month = {October},
   url = {http://dx.doi.org/10.1016/j.ajhg.2016.08.017},
   Abstract = {The ASXL genes (ASXL1, ASXL2, and ASXL3) participate in body
             patterning during embryogenesis and encode proteins involved
             in epigenetic regulation and assembly of transcription
             factors to specific genomic loci. Germline de novo
             truncating variants in ASXL1 and ASXL3 have been
             respectively implicated in causing Bohring-Opitz and
             Bainbridge-Ropers syndromes, which result in overlapping
             features of severe intellectual disability and dysmorphic
             features. ASXL2 has not yet been associated with a human
             Mendelian disorder. In this study, we performed whole-exome
             sequencing in six unrelated probands with developmental
             delay, macrocephaly, and dysmorphic features. All six had de
             novo truncating variants in ASXL2. A careful review enabled
             the recognition of a specific phenotype consisting of
             macrocephaly, prominent eyes, arched eyebrows,
             hypertelorism, a glabellar nevus flammeus, neonatal feeding
             difficulties, hypotonia, and developmental disabilities.
             Although overlapping features with Bohring-Opitz and
             Bainbridge-Ropers syndromes exist, features that distinguish
             the ASXL2-associated condition from ASXL1- and ASXL3-related
             disorders are macrocephaly, absence of growth retardation,
             and more variability in the degree of intellectual
             disabilities. We were also able to demonstrate with mRNA
             studies that these variants are likely to exert a
             dominant-negative effect, given that both alleles are
             expressed in blood and the mutated ASXL2 transcripts escape
             nonsense-mediated decay. In conclusion, de novo truncating
             variants in ASXL2 underlie a neurodevelopmental syndrome
             with a clinically recognizable phenotype. This report
             expands the germline disorders that are linked to the ASXL
             genes.},
   Doi = {10.1016/j.ajhg.2016.08.017},
   Key = {fds319599}
}

@article{fds311652,
   Author = {Willard, VW and Hostetter, SA and Hutchinson, KC and Bonner, MJ and Hardy, KK},
   Title = {Benefit Finding in Maternal Caregivers of Pediatric Cancer
             Survivors: A Mixed Methods Approach.},
   Journal = {J Pediatr Oncol Nurs},
   Volume = {33},
   Number = {5},
   Pages = {353-360},
   Year = {2016},
   Month = {September},
   ISSN = {1043-4542},
   url = {http://dx.doi.org/10.1177/1043454215620119},
   Abstract = {OBJECTIVE: Benefit finding has been described as the
             identification of positive effects resulting from otherwise
             stressful experiences. In this mixed methods study, we
             examined the relations between qualitative themes related to
             benefit finding and quantitative measures of psychosocial
             adjustment and coping as reported by maternal caregivers of
             survivors of pediatric cancer. METHODS: Female caregivers of
             survivors of pediatric cancer (n = 40) completed a
             qualitative questionnaire about their experiences caring for
             their child, along with several quantitative measures.
             Qualitative questionnaires were coded for salient themes,
             including social support and personal growth. Correlation
             matrices evaluated associations between qualitative themes
             and quantitative measures of stress and coping. RESULTS:
             Identified benefits included social support and personal
             growth, as well as child-specific benefits. Total benefits
             reported were significantly positively correlated with
             availability of emotional resources. Coping methods were
             also associated, with accepting responsibility associated
             with fewer identified benefits. CONCLUSION: Despite the
             stress of their child's illness, many female caregivers of
             survivors of pediatric cancer reported finding benefits
             associated with their experience. Benefit finding in this
             sample was associated with better adjustment.},
   Doi = {10.1177/1043454215620119},
   Key = {fds311652}
}

@article{fds330043,
   Author = {Hesdorffer, DC and Shinnar, S and Lax, DN and Pellock, JM and Nordli,
             DR and Seinfeld, S and Gallentine, W and Frank, LM and Lewis, DV and Shinnar, RC and Bello, JA and Chan, S and Epstein, LG and Moshé, SL and Liu, B and Sun, S and FEBSTAT study team},
   Title = {Risk factors for subsequent febrile seizures in the FEBSTAT
             study.},
   Journal = {Epilepsia},
   Volume = {57},
   Number = {7},
   Pages = {1042-1047},
   Year = {2016},
   Month = {July},
   url = {http://dx.doi.org/10.1111/epi.13418},
   Abstract = {OBJECTIVES: To identify risk and risk factors for developing
             a subsequent febrile seizure (FS) in children with a first
             febrile status epilepticus (FSE) compared to a first simple
             febrile seizure (SFS). To identify home use of rescue
             medications for subsequent FS. METHODS: Cases included a
             first FS that was FSE drawn from FEBSTAT and Columbia
             cohorts. Controls were a first SFS. Cases and controls were
             classified according to established FEBSTAT protocols.
             Cumulative risk for subsequent FS over a 5-year period was
             compared in FSE versus SFS, and Cox proportional hazards
             regression was conducted. Separate analysis examined
             subsequent FS within FSE. The use of rescue medications at
             home was assessed for subsequent FS. RESULTS: Risk for a
             subsequent FSE was significantly increased in FSE versus
             SFS. Any magnetic resonance imaging (MRI) abnormality
             increased the risk 3.4-fold (p < 0.05), adjusting for age at
             first FS and FSE and in analyses restricted to children
             whose first FS was FSE (any MRI abnormality hazard ratio
             [HR] 2.9, p < 0.05). The risk for a second FS of any type or
             of subsequent FS lasting >10 min over the 5-year follow-up
             did not differ in FSE versus SFS. Rectal diazepam was
             administered at home to 5 (23.8%) of 21 children with
             subsequent FS lasting ≥10 min. SIGNIFICANCE: Compared to
             controls, FSE was associated with an increased risk for
             subsequent FSE, suggesting the propensity of children with
             an initial prolonged seizure to experience a prolonged
             recurrence. Any baseline MRI abnormality increased the
             recurrence risk when FSE was compared to SFS and when FSE
             was studied alone. A minority of children with a subsequent
             FS lasting 10 min or longer were treated with rectal
             diazepam at home, despite receiving prescriptions after the
             first FSE. This indicates the need to further improve the
             education of clinicians and parents in order to prevent
             subsequent FSE.},
   Doi = {10.1111/epi.13418},
   Key = {fds330043}
}

@article{fds311653,
   Author = {Allen, T and Willard, VW and Anderson, LM and Hardy, KK and Bonner,
             MJ},
   Title = {Social functioning and facial expression recognition in
             children with neurofibromatosis type 1.},
   Journal = {J Intellect Disabil Res},
   Volume = {60},
   Number = {3},
   Pages = {282-293},
   Year = {2016},
   Month = {March},
   ISSN = {0964-2633},
   url = {http://dx.doi.org/10.1111/jir.12248},
   Abstract = {BACKGROUND: This study examined social functioning and
             facial expression recognition (FER) in children with
             neurofibromatosis type 1 (NF1) compared to typically
             developing peers. Specifically, the current research aimed
             to identify hypothesised relationships between
             neurocognitive ability, FER and social functioning. METHOD:
             Children, ages 8 to 16, with NF1 (n = 23) and typically
             developing peers (n = 23) were recruited during
             regularly scheduled clinic visits and through advertisements
             on an institutional clinical trials website, respectively.
             Participants completed a measure of FER, an abbreviated
             intelligence test and questionnaires regarding their quality
             of life and behavioural functioning. Parents were also asked
             to complete questionnaires regarding the social-emotional
             and cognitive functioning of their child. RESULTS: As
             expected, there were significant differences between
             children with NF1 and typically developing peers across
             domains of social functioning and FER. Within the sample of
             children with NF1, there were no significant associations
             observed between cognitive measures, social functioning and
             facial recognition skills. CONCLUSION: Children with NF1
             exhibited high rates of social impairment and weak FER
             skills compared to controls. The absence of associations
             between FER with cognitive and social variables, however,
             suggests something unique about this skill in children with
             NF1. Theoretical comparisons are made to children with
             autism spectrum disorders, as this condition may serve as a
             potentially useful model in better understanding FER in
             children with NF1.},
   Doi = {10.1111/jir.12248},
   Key = {fds311653}
}

@article{fds302231,
   Author = {Ware, RE and Davis, BR and Schultz, WH and Brown, RC and Aygun, B and Sarnaik, S and Odame, I and Fuh, B and George, A and Owen, W and Luchtman-Jones, L and Rogers, ZR and Hilliard, L and Gauger, C and Piccone, C and Lee, MT and Kwiatkowski, JL and Jackson, S and Miller,
             ST and Roberts, C and Heeney, MM and Kalfa, TA and Nelson, S and Imran, H and Nottage, K and Alvarez, O and Rhodes, M and Thompson, AA and Rothman,
             JA and Helton, KJ and Roberts, D and Coleman, J and Bonner, MJ and Kutlar,
             A and Patel, N and Wood, J and Piller, L and Wei, P and Luden, J and Mortier,
             NA and Stuber, SE and Luban, NLC and Cohen, AR and Pressel, S and Adams,
             RJ},
   Title = {Hydroxycarbamide versus chronic transfusion for maintenance
             of transcranial doppler flow velocities in children with
             sickle cell anaemia-TCD With Transfusions Changing to
             Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3,
             non-inferiority trial.},
   Journal = {Lancet},
   Volume = {387},
   Number = {10019},
   Pages = {661-670},
   Year = {2016},
   Month = {February},
   ISSN = {0140-6736},
   url = {http://dx.doi.org/10.1016/S0140-6736(15)01041-7},
   Abstract = {BACKGROUND: For children with sickle cell anaemia and high
             transcranial doppler (TCD) flow velocities, regular blood
             transfusions can effectively prevent primary stroke, but
             must be continued indefinitely. The efficacy of
             hydroxycarbamide (hydroxyurea) in this setting is unknown;
             we performed the TWiTCH trial to compare hydroxyurea with
             standard transfusions. METHODS: TWiTCH was a multicentre,
             phase 3, randomised, open-label, non-inferiority trial done
             at 26 paediatric hospitals and health centres in the USA and
             Canada. We enrolled children with sickle cell anaemia who
             were aged 4-16 years and had abnormal TCD flow velocities
             (≥ 200 cm/s) but no severe vasculopathy. After screening,
             eligible participants were randomly assigned 1:1 to continue
             standard transfusions (standard group) or hydroxycarbamide
             (alternative group). Randomisation was done at a central
             site, stratified by site with a block size of four, and an
             adaptive randomisation scheme was used to balance the
             covariates of baseline age and TCD velocity. The study was
             open-label, but TCD examinations were read centrally by
             observers masked to treatment assignment and previous TCD
             results. Participants assigned to standard treatment
             continued to receive monthly transfusions to maintain 30%
             sickle haemoglobin or lower, while those assigned to the
             alternative treatment started oral hydroxycarbamide at 20
             mg/kg per day, which was escalated to each participant's
             maximum tolerated dose. The treatment period lasted 24
             months from randomisation. The primary study endpoint was
             the 24 month TCD velocity calculated from a general linear
             mixed model, with the non-inferiority margin set at 15 cm/s.
             The primary analysis was done in the intention-to-treat
             population and safety was assessed in all patients who
             received at least one dose of assigned treatment. This study
             is registered with ClinicalTrials.gov, number NCT01425307.
             FINDINGS: Between Sept 20, 2011, and April 17, 2013, 159
             patients consented and enrolled in TWiTCH. 121 participants
             passed screening and were then randomly assigned to
             treatment (61 to transfusions and 60 to hydroxycarbamide).
             At the first scheduled interim analysis, non-inferiority was
             shown and the sponsor terminated the study. Final
             model-based TCD velocities were 143 cm/s (95% CI 140-146) in
             children who received standard transfusions and 138 cm/s
             (135-142) in those who received hydroxycarbamide, with a
             difference of 4·54 (0·10-8·98). Non-inferiority
             (p=8·82 × 10(-16)) and post-hoc superiority (p=0·023)
             were met. Of 29 new neurological events adjudicated
             centrally by masked reviewers, no strokes were identified,
             but three transient ischaemic attacks occurred in each
             group. Magnetic resonance brain imaging and angiography (MRI
             and MRA) at exit showed no new cerebral infarcts in either
             treatment group, but worsened vasculopathy in one
             participant who received standard transfusions. 23 severe
             adverse events in nine (15%) patients were reported for
             hydroxycarbamide and ten serious adverse events in six (10%)
             patients were reported for standard transfusions. The most
             common serious adverse event in both groups was
             vaso-occlusive pain (11 events in five [8%] patients with
             hydroxycarbamide and three events in one [2%] patient for
             transfusions). INTERPRETATION: For high-risk children with
             sickle cell anaemia and abnormal TCD velocities who have
             received at least 1 year of transfusions, and have no
             MRA-defined severe vasculopathy, hydroxycarbamide treatment
             can substitute for chronic transfusions to maintain TCD
             velocities and help to prevent primary stroke. FUNDING:
             National Heart, Lung, and Blood Institute, National
             Institutes of Health.},
   Doi = {10.1016/S0140-6736(15)01041-7},
   Key = {fds302231}
}

@article{fds333035,
   Author = {Mikati, MA and Jiang, Y-H and Carboni, M and Shashi, V and Petrovski, S and Spillmann, R and Milligan, CJ and Li, M and Grefe, A and McConkie, A and Berkovic, S and Scheffer, I and Mullen, S and Bonner, M and Petrou, S and Goldstein, D},
   Title = {Quinidine in the treatment of KCNT1-positive
             epilepsies.},
   Journal = {Ann Neurol},
   Volume = {78},
   Number = {6},
   Pages = {995-999},
   Year = {2015},
   Month = {December},
   url = {http://dx.doi.org/10.1002/ana.24520},
   Abstract = {We report 2 patients with drug-resistant epilepsy caused by
             KCNT1 mutations who were treated with quinidine. Both
             mutations manifested gain of function in vitro, showing
             increased current that was reduced by quinidine. One, who
             had epilepsy of infancy with migrating focal seizures, had
             80% reduction in seizure frequency as recorded in seizure
             diaries, and partially validated by objective seizure
             evaluation on EEG. The other, who had a novel phenotype,
             with severe nocturnal focal and secondary generalized
             seizures starting in early childhood with developmental
             regression, did not improve. Although quinidine represents
             an encouraging opportunity for therapeutic benefits, our
             experience suggests caution in its application and supports
             the need to identify more targeted drugs for KCNT1
             epilepsies.},
   Doi = {10.1002/ana.24520},
   Key = {fds333035}
}

@article{fds299401,
   Author = {Anderson, LM and Allen, TM and Thornburg, CD and Bonner,
             MJ},
   Title = {Fatigue in Children With Sickle Cell Disease: Association
             With Neurocognitive and Social-Emotional Functioning and
             Quality of Life.},
   Journal = {J Pediatr Hematol Oncol},
   Volume = {37},
   Number = {8},
   Pages = {584-589},
   Year = {2015},
   Month = {November},
   ISSN = {1077-4114},
   url = {http://dx.doi.org/10.1097/MPH.0000000000000431},
   Abstract = {Children with sickle cell disease (SCD) report fatigue in
             addition to acute and chronic pain, which can decrease
             overall health-related quality of life (HRQL). The primary
             objective of the current study was to investigate the
             relationship between fatigue and HRQL. Given limited prior
             research, secondary objectives included investigation of
             associations between fatigue and functional outcomes,
             including child neurocognitive and social-emotional
             functioning. Children aged 8 to 16 years (N=32) and a
             caregiver completed measures of fatigue, HRQL, pain, and
             neurocognitive and social-emotional functioning. Controlling
             for pain and number of SCD-related hospitalizations,
             hierarchical linear regression models were used to determine
             the impact of child-reported and parent-reported fatigue on
             child HRQL. Correlational analyses were used to explore the
             relationship between fatigue and additional child outcomes.
             Data indicated that children with SCD experience clinically
             relevant levels of fatigue, which independently predicts
             lower HRQL. Fatigue was also associated with lower working
             memory, executive functioning, and higher levels of
             internalizing symptoms. Given its observed impact on HRQL
             and relationship to functional outcomes, fatigue may be an
             important target of clinical, home, or school interventions.
             This practice may attenuate the burden of fatigue in these
             patients, and in turn, help improve the quality of life of
             children living with SCD.},
   Doi = {10.1097/MPH.0000000000000431},
   Key = {fds299401}
}

@article{fds299403,
   Author = {Shashi, V and Harrell, W and Eack, S and Sanders, C and McConkie-Rosell,
             A and Keshavan, MS and Bonner, MJ and Schoch, K and Hooper,
             SR},
   Title = {Social cognitive training in adolescents with chromosome
             22q11.2 deletion syndrome: feasibility and preliminary
             effects of the intervention.},
   Journal = {J Intellect Disabil Res},
   Volume = {59},
   Number = {10},
   Pages = {902-913},
   Year = {2015},
   Month = {October},
   ISSN = {0964-2633},
   url = {http://dx.doi.org/10.1111/jir.12192},
   Abstract = {BACKGROUND: Children with chromosome 22q11.2 deletion
             syndrome (22q11DS) often have deficits in social cognition
             and social skills that contribute to poor adaptive
             functioning. These deficits may be of relevance to the later
             occurrence of serious psychiatric illnesses such as
             schizophrenia. Yet, there are no evidence-based
             interventions to improve social cognitive functioning in
             children with 22q11DS. METHODS: Using a customised social
             cognitive curriculum, we conducted a pilot small-group-based
             social cognitive training (SCT) programme in 13 adolescents
             with 22q11DS, relative to a control group of nine age- and
             gender-matched adolescents with 22q11DS. RESULTS: We found
             the SCT programme to be feasible, with high rates of
             compliance and satisfaction on the part of the participants
             and their families. Our preliminary analyses indicated that
             the intervention group showed significant improvements in an
             overall social cognitive composite index. CONCLUSIONS: SCT
             in a small-group format for adolescents with 22q11DS is
             feasible and results in gains in social cognition. A larger
             randomised controlled trial would permit assessment of
             efficacy of this promising novel intervention.},
   Doi = {10.1111/jir.12192},
   Key = {fds299403}
}

@article{fds299402,
   Author = {Hardy, KK and Willard, VW and Wigdor, AB and Allen, TM and Bonner,
             MJ},
   Title = {The potential utility of parent-reported attention screening
             in survivors of childhood cancer to identify those in need
             of comprehensive neuropsychological evaluation.},
   Journal = {Neurooncol Pract},
   Volume = {2},
   Number = {1},
   Pages = {32-39},
   Year = {2015},
   Month = {March},
   ISSN = {2054-2577},
   url = {http://dx.doi.org/10.1093/nop/npu026},
   Abstract = {BACKGROUND: Survivors of childhood cancer are at risk for
             neuropsychological late effects, yet identifying those in
             need of evaluation and obtaining needed services can be
             challenging for the medical team. Finding time- and
             cost-effective screening measures that can be used to
             identify children in need of evaluation is a clinical
             priority. Our objective was to investigate the association
             between parent-rated attention problems and related
             neuropsychological impairments in childhood cancer survivors
             as a means of identifying those at high risk for
             difficulties. METHODS: Cognitive and psychosocial data of
             survivors who completed neuropsychological evaluations were
             retrospectively abstracted. Parents of 70 survivors of
             pediatric cancer (mean age, 11.6 years) completed the
             Conners Parent Rating Scale and the Child Behavior
             Checklist. Children also completed a measure of intellectual
             functioning. The 18 symptoms of inattention and
             hyperactivity were abstracted from the Conners
             questionnaire, and participants were classified according to
             whether or not they met attention deficit/hyperactivity
             disorder (ADHD) symptom criteria (≥6 inattentive
             symptoms). RESULTS: Survivors who met symptom criteria for
             ADHD (27%) demonstrated greater impairments in IQ and
             working memory, but not processing speed, than survivors who
             did not. Meeting ADHD symptom criteria was also associated
             with greater externalizing and social problems but not more
             internalizing symptoms. ADHD symptom screening was
             associated with low sensitivity (range = 26.3%-69.2%) but
             stronger specificity (range = 75.0%-82.7%) for
             neuropsychological difficulties. CONCLUSION: Parental
             ratings of attentional symptoms may be a useful way to
             screen survivors who may be in need of a full
             neuropsychological assessment.},
   Doi = {10.1093/nop/npu026},
   Key = {fds299402}
}

@article{fds271051,
   Author = {Schreiber, JE and Gurney, JG and Palmer, SL and Bass, JK and Wang, M and Chen, S and Zhang, H and Swain, M and Chapieski, ML and Bonner, MJ and Mabbott, DJ and Knight, SJ and Armstrong, CL and Boyle, R and Gajjar,
             A},
   Title = {Examination of risk factors for intellectual and academic
             outcomes following treatment for pediatric
             medulloblastoma.},
   Journal = {Neuro Oncol},
   Volume = {16},
   Number = {8},
   Pages = {1129-1136},
   Year = {2014},
   Month = {August},
   ISSN = {1522-8517},
   url = {http://dx.doi.org/10.1093/neuonc/nou006},
   Abstract = {BACKGROUND: The aim of this study was to prospectively
             examine the effects of hearing loss and posterior fossa
             syndrome (PFS), in addition to age at diagnosis and disease
             risk status, on change in intellectual and academic outcomes
             following diagnosis and treatment in a large sample of
             medulloblastoma patients. METHODS: Data from at least 2
             cognitive and academic assessments were available from 165
             patients (ages 3-21 years) treated with surgery,
             risk-adapted craniospinal irradiation, and 4 courses of
             chemotherapy with stem cell support. Patients underwent
             serial evaluation of cognitive and academic functioning from
             baseline up to 5 years post diagnosis. RESULTS: Serious
             hearing loss, PFS, younger age at diagnosis, and high-risk
             status were all significant risk factors for decline in
             intellectual and academic skills. Serious hearing loss and
             PFS independently predicted below-average estimated mean
             intellectual ability at 5 years post diagnosis. Patients
             with high-risk medulloblastoma and young age at diagnosis
             (<7 years) exhibited the largest drop in mean scores for
             intellectual and academic outcomes. CONCLUSIONS: Despite a
             significant decline over time, intellectual and academic
             outcomes remained within the average range at 5 years post
             diagnosis for the majority of patients. Future studies
             should determine if scores remain within the average range
             at time points further out from treatment. Patients at
             heightened risk should be closely monitored and provided
             with recommendations for appropriate interventions.},
   Doi = {10.1093/neuonc/nou006},
   Key = {fds271051}
}

@article{fds271045,
   Author = {Knight, SJ and Conklin, HM and Palmer, SL and Schreiber, JE and Armstrong, CL and Wallace, D and Bonner, M and Swain, MA and Evankovich,
             KD and Mabbott, DJ and Boyle, R and Huang, Q and Zhang, H and Anderson, VA and Gajjar, A},
   Title = {Working memory abilities among children treated for
             medulloblastoma: parent report and child
             performance.},
   Journal = {J Pediatr Psychol},
   Volume = {39},
   Number = {5},
   Pages = {501-511},
   Year = {2014},
   Month = {June},
   ISSN = {0146-8693},
   url = {http://dx.doi.org/10.1093/jpepsy/jsu009},
   Abstract = {OBJECTIVE: We investigated the 5-year postsurgical
             developmental trajectory of working memory (WM) in children
             with medulloblastoma using parent and performance-based
             measures. METHOD: This study included 167 patients treated
             for medulloblastoma. Serial assessments of WM occurred at
             predetermined time points for 5 years. RESULTS: There was a
             subtle, statistically significant increase in parental
             concern about WM, coupled with a statistically significant
             decrease in age-standardized scores on performance-based
             measures. However, whole-group mean scores on both parent
             and performance-based measures remained in the age-expected
             range. Posterior fossa syndrome was consistently associated
             with poorer WM. Younger age at treatment and higher
             treatment intensity were associated with greater negative
             change in WM performance only. CONCLUSIONS: Most children
             treated for medulloblastoma display WM within the
             age-appropriate range according to parent report and
             performance. However, the subtle negative changes over time
             and identified subgroups at increased risk highlight the
             need for ongoing monitoring of this population.},
   Doi = {10.1093/jpepsy/jsu009},
   Key = {fds271045}
}

@article{fds271046,
   Author = {Reddick, WE and Taghipour, DJ and Glass, JO and Ashford, J and Xiong, X and Wu, S and Bonner, M and Khan, RB and Conklin, HM},
   Title = {Prognostic factors that increase the risk for reduced white
             matter volumes and deficits in attention and learning for
             survivors of childhood cancers.},
   Journal = {Pediatr Blood Cancer},
   Volume = {61},
   Number = {6},
   Pages = {1074-1079},
   Year = {2014},
   Month = {June},
   ISSN = {1545-5009},
   url = {http://dx.doi.org/10.1002/pbc.24947},
   Abstract = {OBJECTIVE: In children, CNS-directed cancer therapy is
             thought to result in decreased cerebral white matter volumes
             (WMV) and subsequent neurocognitive deficits. This study was
             designed as a prospective validation of the purported
             reduction in WMV, associated influential factors, and its
             relationship to neurocognitive deficits in a very large
             cohort of both acute lymphoblastic leukemia (ALL) and
             malignant brain tumors (BT) survivors in comparison to an
             age similar cohort of healthy sibling controls. PROCEDURES:
             The effects of host characteristics and CNS treatment
             intensity on WMV were investigated in 383 childhood cancer
             survivors (199 ALL, 184 BT) at least 12 months
             post-completion of therapy and 67 healthy siblings that
             served as a control group. t-Tests and multiple variable
             linear models were used to assess cross-sectional WMV and
             its relation with neurocognitive function. RESULTS: BT
             survivors had lower WMV than ALL survivors, who had less
             than the control group. Increased CNS treatment intensity,
             younger age at treatment, and greater time since treatment
             were significantly associated with lower WMV. Additionally,
             cancer survivors did not perform as well as the control
             group on neurocognitive measures of intelligence, attention,
             and academic achievement. Reduced WMV had a larger impact on
             estimated IQ among females and children treated at a younger
             age. CONCLUSIONS: Survivors of childhood cancer that have
             undergone higher intensity therapy at a younger age have
             significantly less WMV than their peers and this difference
             increases with time since therapy. Decreased WMV is
             associated with significantly lower scores in intelligence,
             attention, and academic performance in survivors.},
   Doi = {10.1002/pbc.24947},
   Key = {fds271046}
}

@article{fds271047,
   Author = {Anderson, LM and Allen, TM and Nambuba, J and Thornburg, CD and Bonner,
             MJ},
   Title = {Predictors of Fatigue in Children with Sickle Cell
             Disease},
   Journal = {JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS},
   Volume = {35},
   Number = {2},
   Pages = {S12-S12},
   Publisher = {LIPPINCOTT WILLIAMS & WILKINS},
   Year = {2014},
   Month = {February},
   ISSN = {0196-206X},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000336849800047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271047}
}

@article{fds271048,
   Author = {Allen, TM and Anderson, LM and Nambuba, J and Thornburg, CD and Bonner,
             MJ},
   Title = {The Impact of Cognitive Functioning on Quality of Life in
             Children with Sickle Cell Disease},
   Journal = {JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS},
   Volume = {35},
   Number = {2},
   Pages = {S11-S11},
   Publisher = {LIPPINCOTT WILLIAMS & WILKINS},
   Year = {2014},
   Month = {February},
   ISSN = {0196-206X},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000336849800042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271048}
}

@article{fds271049,
   Author = {Serafini, S and Komisarow, JM and Gallentine, W and Mikati, MA and Bonner, MJ and Kranz, PG and Haglund, MM and Grant,
             G},
   Title = {Reorganization and stability for motor and language areas
             using cortical stimulation: case example and review of the
             literature.},
   Journal = {Brain Sci},
   Volume = {3},
   Number = {4},
   Pages = {1597-1614},
   Year = {2013},
   Month = {November},
   url = {http://dx.doi.org/10.3390/brainsci3041597},
   Abstract = {The cerebral organization of language in epilepsy patients
             has been studied with invasive procedures such as Wada
             testing and electrical cortical stimulation mapping and more
             recently with noninvasive neuroimaging techniques, such as
             functional MRI. In the setting of a chronic seizure
             disorder, clinical variables have been shown to contribute
             to cerebral language reorganization underscoring the need
             for language lateralization and localization procedures. We
             present a 14-year-old pediatric patient with a refractory
             epilepsy disorder who underwent two neurosurgical resections
             of a left frontal epileptic focus separated by a year. He
             was mapped extraoperatively through a subdural grid using
             cortical stimulation to preserve motor and language
             functions. The clinical history and extensive workup prior
             to surgery is discussed as well as the opportunity to
             compare the cortical maps for language, motor, and sensory
             function before each resection. Reorganization in cortical
             tongue sensory areas was seen concomitant with a new zone of
             ictal and interictal activity in the previous tongue sensory
             area. Detailed neuropsychological data is presented before
             and after any surgical intervention to hypothesize about the
             extent of reorganization between epochs. We conclude that
             intrahemispheric cortical plasticity does occur following
             frontal lobe resective surgery in a teenager with medically
             refractory seizures.},
   Doi = {10.3390/brainsci3041597},
   Key = {fds271049}
}

@article{fds271054,
   Author = {Alvarez, O and Yovetich, NA and Scott, JP and Owen, W and Miller, ST and Schultz, W and Lockhart, A and Aygun, B and Flanagan, J and Bonner, M and Mueller, BU and Ware, RE and Investigators of the Stroke With
             Transfusions Changing to Hydroxyurea Clinical Trial
             (SWiTCH)},
   Title = {Pain and other non-neurological adverse events in children
             with sickle cell anemia and previous stroke who received
             hydroxyurea and phlebotomy or chronic transfusions and
             chelation: results from the SWiTCH clinical
             trial.},
   Journal = {Am J Hematol},
   Volume = {88},
   Number = {11},
   Pages = {932-938},
   Year = {2013},
   Month = {November},
   ISSN = {0361-8609},
   url = {http://dx.doi.org/10.1002/ajh.23547},
   Abstract = {To compare the non-neurological events in children with
             sickle cell anemia (SCA) and previous stroke enrolled in
             SWiTCH. The NHLBI-sponsored Phase III multicenter randomized
             clinical trial stroke with transfusions changing to
             hydroxyurea (SWiTCH) (ClinicalTrials.gov NCT00122980)
             compared continuation of chronic blood transfusion/iron
             chelation to switching to hydroxyurea/phlebotomy for
             secondary stroke prevention and management of iron overload.
             All randomized children were included in the analysis
             (intention to treat). The Fisher's Exact test was used to
             compare the frequency of subjects who experienced at least
             one SCA-related adverse event (AE) or serious adverse event
             (SAE) in each arm and to compare event rates. One hundred
             and thirty three subjects, mean age 13 ± 3.9 years (range
             5.2-19.0 years) and mean time of 7 years on chronic
             transfusion at study entry, were randomized and treated.
             Numbers of subjects experiencing non-neurological AEs were
             similar in the two treatment arms, including SCA-related
             events, SCA pain events, and low rates of acute chest
             syndrome and infection. However, fewer children continuing
             transfusion/chelation experienced SAEs (P = 0.012),
             SCA-related SAEs (P = 0.003), and SCA pain SAEs (P = 0.016)
             as compared to children on the hydroxyurea/phlebotomy arm.
             The timing of phlebotomy did not influence SAEs. Older age
             at baseline predicted having at least 1 SCA pain event.
             Patients with recurrent neurological events during SWiTCH
             were not more likely to experience pain. In children with
             SCA and prior stroke, monthly transfusions and daily iron
             chelation provided superior protection against acute
             vaso-occlusive pain SAEs when compared to hydroxyurea and
             monthly phlebotomy.},
   Doi = {10.1002/ajh.23547},
   Key = {fds271054}
}

@article{fds271057,
   Author = {Palmer, SL and Armstrong, C and Onar-Thomas, A and Wu, S and Wallace, D and Bonner, MJ and Schreiber, J and Swain, M and Chapieski, L and Mabbott,
             D and Knight, S and Boyle, R and Gajjar, A},
   Title = {Processing speed, attention, and working memory after
             treatment for medulloblastoma: an international,
             prospective, and longitudinal study.},
   Journal = {J Clin Oncol},
   Volume = {31},
   Number = {28},
   Pages = {3494-3500},
   Year = {2013},
   Month = {October},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/23980078},
   Abstract = {PURPOSE: The current study prospectively examined processing
             speed (PS), broad attention (BA), and working memory (WM)
             ability of patients diagnosed with medulloblastoma over a
             5-year period. PATIENTS AND METHODS: The study included 126
             patients, ages 3 to 21 years at diagnosis, enrolled onto a
             collaborative protocol for medulloblastoma. Patients were
             treated with postsurgical risk-adapted craniospinal
             irradiation (n = 36 high risk [HR]; n = 90 average risk)
             followed by four cycles of high-dose chemotherapy with
             stem-cell support. Patients completed 509 neuropsychological
             evaluations using the Woodcock-Johnson Tests of Cognitive
             Abilities Third Edition (median of three observations per
             patient). RESULTS: Linear mixed effects models revealed that
             younger age at diagnosis, HR classification, and higher
             baseline scores were significantly associated with poorer
             outcomes in PS. Patients treated as HR and those with higher
             baseline scores are estimated to have less favorable
             outcomes in WM and BA over time. Parent education and
             marital status were significantly associated with BA and WM
             baseline scores but not change over time. CONCLUSION: Of the
             three key domains, PS was estimated to have the lowest
             scores at 5 years after diagnosis. Identifying cognitive
             domains most vulnerable to decline should guide researchers
             who are aiming to develop efficacious cognitive intervention
             and rehabilitation programs, thereby improving the quality
             of survivorship for the pediatric medulloblastoma
             population.},
   Doi = {10.1200/JCO.2012.47.4775},
   Key = {fds271057}
}

@article{fds271053,
   Author = {Harrell, W and Eack, S and Hooper, SR and Keshavan, MS and Bonner, MS and Schoch, K and Shashi, V},
   Title = {Feasibility and preliminary efficacy data from a
             computerized cognitive intervention in children with
             chromosome 22q11.2 deletion syndrome.},
   Journal = {Res Dev Disabil},
   Volume = {34},
   Number = {9},
   Pages = {2606-2613},
   Year = {2013},
   Month = {September},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/23751300},
   Abstract = {Children with chromosome 22q11.2 deletion syndrome (22q11DS)
             are significantly impaired in their academic performance and
             functionality due to cognitive deficits, especially in
             attention, memory, and other facets of executive function.
             Compounding these cognitive deficits is the remarkably high
             risk of major psychoses, occurring in 25% of adolescents and
             adults with the disorder. There are currently no
             evidence-based interventions designed to improve the
             cognitive deficits in these individuals. We implemented a
             neuroplasticity-based computerized cognitive remediation
             program for 12 weeks in 13 adolescents with 22q11DS,
             assessed feasibility, and measured changes in cognition
             before and after the intervention compared to a control
             group of 10 age- and gender-matched children with 22q11DS.
             Our results indicated that despite their cognitive
             impairments, this intervention is feasible in children with
             22q11DS, with high rates of adherence and satisfaction. Our
             preliminary analyses indicate that gains in cognition occur
             with the intervention. Further study in a larger randomized
             controlled trial would enable assessment of efficacy of this
             novel intervention.},
   Doi = {10.1016/j.ridd.2013.05.009},
   Key = {fds271053}
}

@article{fds271090,
   Author = {Hardy, KK and Willard, VW and Allen, TM and Bonner,
             MJ},
   Title = {Working memory training in survivors of pediatric cancer: a
             randomized pilot study.},
   Journal = {Psychooncology},
   Volume = {22},
   Number = {8},
   Pages = {1856-1865},
   Year = {2013},
   Month = {August},
   ISSN = {1057-9249},
   url = {http://dx.doi.org/10.1002/pon.3222},
   Abstract = {OBJECTIVES: Survivors of pediatric brain tumors and acute
             lymphoblastic leukemia (ALL) are at increased risk for
             neurocognitive deficits, but few empirically supported
             treatment options exist. We examined the feasibility and
             preliminary efficacy of a home-based, computerized working
             memory training program, CogmedRM, with survivors of
             childhood cancer. METHODS: Survivors of brain tumors or ALL
             (n = 20) with identified deficits in attention and/or
             working memory were randomized to either the success-adapted
             computer intervention or a non-adaptive, active control
             condition. Specifically, children in the adaptive condition
             completed exercises that became more challenging with each
             correct trial, whereas those in the non-adaptive version
             trained with exercises that never increased in difficulty.
             All participants were asked to complete 25 training sessions
             at home, with weekly, phone-based coaching support. Brief
             assessments were completed pre-intervention and
             post-intervention; outcome measures included both
             performance-based and parent-report measures of working
             memory and attention. RESULTS: Eighty-five percent of
             survivors were compliant with the intervention, with no
             adverse events reported. After controlling for baseline
             intellectual functioning, survivors who completed the
             intervention program evidenced significant post-training
             improvements in their visual working memory and in
             parent-rated learning problems compared with those in the
             active control group. No differences in verbal working
             memory functioning were evident between groups, however.
             CONCLUSIONS: Home-based, computerized cognitive training
             demonstrates good feasibility and acceptability in our
             sample. Children with higher intellectual functioning at
             baseline appeared to benefit more from the training,
             although further study is needed to clarify the strength,
             scope, and particularly the generalizability of potential
             treatment effects.},
   Doi = {10.1002/pon.3222},
   Key = {fds271090}
}

@article{fds271050,
   Author = {Anderson, LM and Allen, TM and Andrzejewski, L and Thornburg, CD and Bonner, MJ},
   Title = {Fatigue in Children with Sickle Cell Disease: Impact on
             Quality of Life},
   Journal = {JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS},
   Volume = {34},
   Number = {6},
   Pages = {S1-S1},
   Publisher = {LIPPINCOTT WILLIAMS & WILKINS},
   Year = {2013},
   Month = {July},
   ISSN = {0196-206X},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330358800004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271050}
}

@article{fds271094,
   Author = {Brinkman, TM and Palmer, SL and Chen, S and Zhang, H and Evankovich, K and Swain, MA and Bonner, MJ and Janzen, L and Knight, S and Armstrong, CL and Boyle, R and Gajjar, A},
   Title = {Parent-reported social outcomes after treatment for
             pediatric embryonal tumors: a prospective longitudinal
             study.},
   Journal = {J Clin Oncol},
   Volume = {30},
   Number = {33},
   Pages = {4134-4140},
   Year = {2012},
   Month = {November},
   ISSN = {0732-183X},
   url = {http://dx.doi.org/10.1200/JCO.2011.40.6702},
   Abstract = {PURPOSE: To examine longitudinal parent-reported social
             outcomes for children treated for pediatric embryonal brain
             tumors. PATIENTS AND METHODS: Patients (N=220) were enrolled
             onto a multisite clinical treatment protocol. Parents
             completed the Child Behavior Checklist/6-18 at the time of
             their child's diagnosis and yearly thereafter. A generalized
             linear mixed effects model regression approach was used to
             examine longitudinal changes in parent ratings of social
             competence, social problems, and withdrawn/depressed
             behaviors with demographic and treatment factors as
             covariates. RESULTS: During the 5-year period following
             diagnosis and treatment, few patients were reported to have
             clinically elevated scores on measures of social
             functioning. Mean scores differed significantly from
             population norms, yet remained within the average range.
             Several factors associated with unfavorable patterns of
             change in social functioning were identified. Patients with
             high-risk treatment status had a greater increase in
             parent-reported social problems (P=.001) and
             withdrawn/depressed behaviors (P=.01) over time compared
             with average-risk patients. Patients with posterior fossa
             syndrome had greater parent-reported social problems over
             time (P=.03). Female patients showed higher
             withdrawn/depressed scores over time compared with male
             patients (P<.001). Patient intelligence, age at diagnosis,
             and parent education level also contributed to parent report
             of social functioning. CONCLUSION: Results of this study
             largely suggest positive social adjustment several years
             after diagnosis and treatment of a pediatric embryonal
             tumor. However, several factors, including treatment risk
             status and posterior fossa syndrome, may be important
             precursors of long-term social outcomes. Future research is
             needed to elucidate the trajectory of social functioning as
             these patients transition into adulthood.},
   Doi = {10.1200/JCO.2011.40.6702},
   Key = {fds271094}
}

@article{fds271097,
   Author = {Brown, RT and Shaftman, SR and Tilley, BC and Anthony, KK and Kral, MC and Maxson, B and Mee, L and Bonner, MJ and Vogler, LB and Schanberg, LE and Connelly, MA and Wagner, JL and Silver, RM and Nietert,
             PJ},
   Title = {The health education for lupus study: a randomized
             controlled cognitive-behavioral intervention targeting
             psychosocial adjustment and quality of life in adolescent
             females with systemic lupus erythematosus.},
   Journal = {Am J Med Sci},
   Volume = {344},
   Number = {4},
   Pages = {274-282},
   Year = {2012},
   Month = {October},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/22996139},
   Abstract = {INTRODUCTION: To examine in a randomize controlled
             feasibility clinical trial the efficacy of a
             cognitive-behavioral intervention designed to manage pain,
             enhance disease adjustment and adaptation and improve
             quality of life among female adolescents with systemic lupus
             erythematosus. METHODS: Female adolescents (n = 53) ranging
             in age from 12 to 18 years were randomly assigned to 1 of 3
             groups including a cognitive-behavioral intervention, an
             education-only arm and a no-contact control group.
             Participants were assessed at baseline, postintervention and
             at 3- and 6-month intervals after completion of the
             intervention. RESULTS: No significant differences were
             revealed among the 3 treatment arms for any of the dependent
             measures at any of the assessment points. For the mediator
             variables, a posthoc secondary analysis did reveal increases
             in coping skills from baseline to postintervention among the
             participants in the cognitive-behavioral intervention group
             compared with both the no-contact control group and the
             education-only group. CONCLUSION: Although no differences
             were detected in the primary outcome, a possible effect on
             coping of female adolescents with systemic lupus
             erythematosus was detected in this feasibility study.
             Whether the impact of training in the area of coping was of
             sufficient magnitude to generalize to other areas of
             functioning, such as adjustment and adaptation, is unclear.
             Future phase III randomized trials will be needed to assess
             additional coping models and to evaluate the dose of
             training and its influence on pain management, adjustment
             and health-related quality of life.},
   Doi = {10.1097/MAJ.0b013e3182449be9},
   Key = {fds271097}
}

@article{fds271093,
   Author = {Ashley, DM and Merchant, TE and Strother, D and Zhou, T and Duffner, P and Burger, PC and Miller, DC and Lyon, N and Bonner, MJ and Msall, M and Buxton, A and Geyer, R and Kun, LE and Coleman, L and Pollack,
             IF},
   Title = {Induction chemotherapy and conformal radiation therapy for
             very young children with nonmetastatic medulloblastoma:
             Children's Oncology Group study P9934.},
   Journal = {J Clin Oncol},
   Volume = {30},
   Number = {26},
   Pages = {3181-3186},
   Year = {2012},
   Month = {September},
   ISSN = {0732-183X},
   url = {http://dx.doi.org/10.1200/JCO.2010.34.4341},
   Abstract = {PURPOSE: P9934 was a prospective trial of systemic
             chemotherapy, second surgery, and conformal radiation
             therapy (CRT) limited to the posterior fossa and primary
             site for children between 8 months and 3 years old with
             nonmetastatic medulloblastoma. The study was open from June
             2000 until June 2006. PATIENTS AND METHODS: After initial
             surgery, children received four cycles of induction
             chemotherapy, followed by age- and response-adjusted CRT to
             the posterior fossa (18 or 23.4 Gy) and tumor bed
             (cumulative 50.4 or 54 Gy) and maintenance chemotherapy.
             Neurodevelopmental outcomes were evaluated and event-free
             survival (EFS) results were directly compared with a
             previous study of multiagent chemotherapy without
             irradiation (Pediatric Oncology Group [POG] trial 9233).
             RESULTS: Seventy-four patients met eligibility requirements.
             The 4-year EFS and overall survival probabilities were 50%
             ± 6% and 69% ± 5.5%, respectively, which compared
             favorably to the results from POG 9233. Analysis showed that
             the desmoplastic/nodular subtype was a favorable factor in
             predicting survival. Our 4-year EFS rate was 58% ± 8% for
             patients with desmoplasia. Whereas seven of 10 patients who
             had disease progression before CRT had primary-site failure,
             15 of 19 patients who progressed after CRT had distant-site
             failure. Neurodevelopmental assessments did not show a
             decline in cognitive or motor function after
             protocol-directed chemotherapy and CRT. CONCLUSION: The
             addition of CRT to postoperative chemotherapy in young
             children with nonmetastatic medulloblastoma increased
             event-free survival compared with the use of postoperative
             chemotherapy alone. Future studies will use histopathologic
             typing (desmoplastic/nodular versus nondesmoplastic/nodular)
             to stratify patients for therapy by risk of
             relapse.},
   Doi = {10.1200/JCO.2010.34.4341},
   Key = {fds271093}
}

@article{fds271092,
   Author = {Panepinto, JA and Bonner, M},
   Title = {Health-related quality of life in sickle cell disease: past,
             present, and future.},
   Journal = {Pediatr Blood Cancer},
   Volume = {59},
   Number = {2},
   Pages = {377-385},
   Year = {2012},
   Month = {August},
   ISSN = {1545-5009},
   url = {http://dx.doi.org/10.1002/pbc.24176},
   Abstract = {Health-related quality of life (HRQL) is defined as the
             patient's appraisal of how his/her well being and level of
             functioning, compared to the perceived ideal, are affected
             by individual health. The study of HRQL in children and
             adults with sickle cell disease (SCD) has begun to flourish.
             Given the devastating complications of the disease and other
             co-morbid factors patients experience that influence HRQL,
             it is increasingly important to understand HRQL. The focus
             of this critical review was to examine past and current
             research in HRQL in SCD where a validated instrument was
             used. In addition, future directions for HRQL in SCD are
             explored.},
   Doi = {10.1002/pbc.24176},
   Key = {fds271092}
}

@article{fds271091,
   Author = {Palmer, SL and Lesh, S and Wallace, D and Bonner, MJ and Swain, M and Chapieski, L and Janzen, L and Mabbott, D and Knight, S and Boyle, R and Armstrong, CL and Gajjar, A},
   Title = {How parents cope with their child's diagnosis and treatment
             of an embryonal tumor: results of a prospective and
             longitudinal study.},
   Journal = {J Neurooncol},
   Volume = {105},
   Number = {2},
   Pages = {253-259},
   Year = {2011},
   Month = {November},
   ISSN = {0167-594X},
   url = {http://dx.doi.org/10.1007/s11060-011-0574-9},
   Abstract = {The current study reports longitudinal coping responses
             among parents of children diagnosed with an embryonal brain
             tumor. Patients (n = 219) were enrolled on a treatment
             protocol for a pediatric embryonal brain tumor. Their
             parents (n = 251) completed the Coping Response Inventory at
             time of their child's diagnosis and yearly thereafter,
             resulting in 502 observations. Outcomes were examined with
             patient and parent age at diagnosis, patient risk, parent
             gender and education as covariates. At the time of
             diagnosis, the highest observed coping method was seeking
             guidance with well above average scores (T = 61.6). Over
             time, younger parents were found to seek guidance at a
             significantly higher rate than older parents (P = .016) and
             the use of acceptance resignation and seeking alternative
             results by all parents significantly increased (P = .011 and
             P < .0001 respectively). The use of emotional discharge was
             also observed above average at time of diagnosis (T = 55.4)
             with younger fathers being more likely to exhibit emotional
             discharge than older fathers (P = .002). Differences in
             coping according to age of the patient and parent education
             level are also discussed. Results show a high need for
             guidance, and above average emotional discharge, especially
             among younger parents. It is imperative for the healthcare
             team to lead with accurate information so that these parents
             may make informed decisions about the care of their child.
             This need remains high years after diagnosis. Therefore it
             is critical to continue a consistent level of effective
             communication and support, even following
             treatment.},
   Doi = {10.1007/s11060-011-0574-9},
   Key = {fds271091}
}

@article{fds271088,
   Author = {Hubal, RC and Bonner, MJ and Hardy, KK and Fitzgerald, DP and Willard,
             VW and Allen, TM},
   Title = {Technical aspects and testing of a program to assess
             deficits in facial expression recognition in childhood
             cancer survivors},
   Journal = {Journal of Cyber Therapy and Rehabilitation},
   Volume = {4},
   Number = {3},
   Pages = {363-369},
   Year = {2011},
   Month = {October},
   ISSN = {1784-9934},
   Abstract = {The research presented here focuses on the ease of use of an
             instrument's interface for a target pediatric population,
             where participants were asked to interpret virtual character
             facial expressions. Fortyone children, both pediatric cancer
             survivors and healthy recruits, took part in six tasks that
             had them describe or express their confidence in
             descriptions of different facial expressions, portrayed
             either overtly or subtly and dynamically or statically by
             eight virtual characters. In this test of usability and
             feasibility, childhood cancer survivors performed comparably
             to healthy participants, suggesting that this instrument is
             feasible for use with cancer patients. © Virtual Reality
             Medical Institute.},
   Key = {fds271088}
}

@article{fds271067,
   Author = {Allen, TM and Willard, VW and Hardy, KK and Bonner,
             MJ},
   Title = {THE RELATIONSHIP BETWEEN NEUROCOGNITIVE ABILITY AND
             PSYCHOSOCIAL FUNCTIONING IN CHILDREN WITH NEUROFIBROMATOSIS
             TYPE 1},
   Journal = {ANNALS OF BEHAVIORAL MEDICINE},
   Volume = {41},
   Pages = {S180-S180},
   Publisher = {SPRINGER},
   Year = {2011},
   Month = {April},
   ISSN = {0883-6612},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000289297701189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271067}
}

@article{fds271086,
   Author = {Hardy, KK and Willard, VW and Bonner, MJ},
   Title = {Computerized cognitive training in survivors of childhood
             cancer: a pilot study.},
   Journal = {J Pediatr Oncol Nurs},
   Volume = {28},
   Number = {1},
   Pages = {27-33},
   Year = {2011},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/20966158},
   Abstract = {The objective of the current study was to pilot a
             computerized cognitive training program, Captain's Log, in a
             small sample of survivors of childhood cancer. A total of 9
             survivors of acute lymphoblastic leukemia and brain tumors
             with attention and working memory deficits were enrolled in
             a home-based 12-week cognitive training program. Survivors
             returned for follow-up assessments postintervention and 3
             months later. The intervention was associated with good
             feasibility and acceptability. Participants exhibited
             significant increases in working memory and decreases in
             parent-rated attention problems following the intervention.
             Findings indicate that home-based, computerized cognitive
             intervention is a promising intervention for survivors with
             cognitive late effects; however, further study is warranted
             with a larger sample.},
   Doi = {10.1177/1043454210377178},
   Key = {fds271086}
}

@article{fds271087,
   Author = {Palmer, SL and Hassall, T and Evankovich, K and Mabbott, DJ and Bonner,
             M and Deluca, C and Cohn, R and Fisher, MJ and Morris, EB and Broniscer, A and Gajjar, A},
   Title = {Neurocognitive outcome 12 months following cerebellar mutism
             syndrome in pediatric patients with medulloblastoma.},
   Journal = {Neuro Oncol},
   Volume = {12},
   Number = {12},
   Pages = {1311-1317},
   Year = {2010},
   Month = {December},
   ISSN = {1522-8517},
   url = {http://dx.doi.org/10.1093/neuonc/noq094},
   Abstract = {The aim is to prospectively assess early neurocognitive
             outcome of children who developed cerebellar mutism syndrome
             (CMS) following surgical resection of a posterior fossa
             embryonal tumor, compared with carefully matched control
             patients. Children who were enrolled on an ongoing
             IRB-approved protocol for treatment of embryonal tumors,
             were diagnosed with postoperative CMS, and had completed
             prospectively planned neuropsychological evaluation at 12
             months postdiagnosis were considered eligible. The cognitive
             outcomes of these patients were examined in comparison to
             patients without CMS from the same treatment protocol and
             matched with regard to primary diagnosis, age at diagnosis,
             and risk/corresponding treatment (n = 22 pairs). Seventeen
             were also matched according to gender, and 14 were also
             matched according to race. High-risk patients received
             36-39.6 Gy CSI and 3D conformal boost to the primary site to
             55.8-59.4 Gy. Average-risk patients received 23.4 Gy CSI and
             3D conformal boost to the primary site to 55.8 Gy.
             Significant group differences were found on multiple
             cognitive outcomes. While the matched control patients
             exhibited performance in the average range, patients who
             developed CMS postsurgery were found to have significantly
             lower performance in processing speed, attention, working
             memory, executive processes, cognitive efficiency, reading,
             spelling, and math. Patients treated for medulloblastoma who
             experience postoperative CMS show an increased risk for
             neurocognitive impairment, evident as early as 12 months
             following diagnosis. This study highlights the need for
             careful follow-up with neuropsychological evaluation and for
             obtaining critical support for patients and their
             families.},
   Doi = {10.1093/neuonc/noq094},
   Key = {fds271087}
}

@article{fds271085,
   Author = {Conklin, HM and Reddick, WE and Ashford, J and Ogg, S and Howard, SC and Morris, EB and Brown, R and Bonner, M and Christensen, R and Wu, S and Xiong, X and Khan, RB},
   Title = {Long-term efficacy of methylphenidate in enhancing attention
             regulation, social skills, and academic abilities of
             childhood cancer survivors.},
   Journal = {J Clin Oncol},
   Volume = {28},
   Number = {29},
   Pages = {4465-4472},
   Year = {2010},
   Month = {October},
   ISSN = {0732-183X},
   url = {http://dx.doi.org/10.1200/JCO.2010.28.4026},
   Abstract = {PURPOSE: Methylphenidate (MPH) ameliorates attention
             problems experienced by some cancer survivors in the short
             term, but its long-term efficacy is unproven. PATIENTS AND
             METHODS: This study investigates the long-term effectiveness
             of maintenance doses of MPH in survivors of childhood brain
             tumors (n = 35) and acute lymphoblastic leukemia (n = 33)
             participating in a 12-month MPH trial. Measures of attention
             (Conners' Continuous Performance Test [CPT], Conners' Rating
             Scales [CRS]), academic abilities (Wechsler Individual
             Achievement Test [WIAT]), social skills (Social Skills
             Rating System [SSRS]), and behavioral problems (Child
             Behavior Checklist [CBCL]) were administered at
             premedication baseline and at the end of the MPH trial while
             on medication. A cancer control group composed of patients
             who were not administered MPH (brain tumor = 31 and acute
             lymphoblastic leukemia = 23) was assessed on the same
             measures 12 [corrected] months apart. RESULTS: For the MPH
             group, repeated measures analysis of variance revealed
             significant improvement in performance on a measure of
             sustained attention (CPT indices, P < .05); parent, teacher,
             and self-report ratings of attention (CRS indices, P < .05),
             and parent ratings of social skills or behavioral problems
             (SSRS and CBCL indices; P < .05). In contrast, the cancer
             control group only showed improvement on parent ratings of
             attention (Conners' Parent Rating Scale indices; P < .05)
             and social skills (SSRS and CBCL indices; P < .05). There
             was no significant improvement on the academic measure
             (WIAT) in either group. CONCLUSION: Attention and behavioral
             benefits of MPH for childhood cancer survivors are
             maintained across settings over the course of a year.
             Although academic gains were not identified, MPH may offer
             benefits in academic areas not assessed.},
   Doi = {10.1200/JCO.2010.28.4026},
   Key = {fds271085}
}

@article{fds271084,
   Author = {Paxton, RJ and Jones, LW and Rosoff, PM and Bonner, M and Ater, JL and Demark-Wahnefried, W},
   Title = {Associations between leisure-time physical activity and
             health-related quality of life among adolescent and adult
             survivors of childhood cancers.},
   Journal = {Psychooncology},
   Volume = {19},
   Number = {9},
   Pages = {997-1003},
   Year = {2010},
   Month = {September},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19918964},
   Abstract = {OBJECTIVE: Survivors of childhood cancer are at an increased
             risk for reduced quality of life (QOL), yet few studies have
             explored factors associated with improving health-related
             QOL (HRQOL) in this population. We thus explored the
             relationship between physical activity (PA) and HRQOL among
             survivors of childhood cancer. METHODS: A total of 215
             survivors of childhood lymphoma, leukemia, and central
             nervous system cancers completed mailed surveys that
             elicited information regarding leisure-time PA (LTPA)
             measured in metabolic equivalents, HRQOL, and diagnostic and
             demographic factors. Correlations and adjusted regression
             models were used to explore the relationship between LTPA
             and HRQOL. RESULTS: In the total sample, modest, yet
             significant linear associations were observed between LTPA
             and overall HRQOL (beta=0.17, p<0.01), as well as each of
             the respective subscales (beta=0.11-0.23 and p's<0.05 to
             <0.001). Among adolescent survivors of childhood cancer,
             LTPA was significantly associated with overall HRQOL
             (beta=0.27), cancer worry (beta=0.36), cognitive function
             (beta=0.32), body appearance (beta=0.29), and social
             function (beta=0.27) (all p's<0.05). Among adult survivors
             of childhood cancer, LTPA was only significantly associated
             with physical function (beta=0.28, p<0.001). CONCLUSIONS:
             Significant associations exist between LTPA and HRQOL;
             however, the association was stronger and observed in more
             domains for adolescent survivors of childhood cancer. More
             research is needed to determine the antecedents and
             consequences of PA in this population.},
   Doi = {10.1002/pon.1654},
   Key = {fds271084}
}

@article{fds271082,
   Author = {Conklin, HM and Helton, S and Ashford, J and Mulhern, RK and Reddick,
             WE and Brown, R and Bonner, M and Jasper, BW and Wu, S and Xiong, X and Khan,
             RB},
   Title = {Predicting methylphenidate response in long-term survivors
             of childhood cancer: a randomized, double-blind,
             placebo-controlled, crossover trial.},
   Journal = {J Pediatr Psychol},
   Volume = {35},
   Number = {2},
   Pages = {144-155},
   Year = {2010},
   Month = {March},
   ISSN = {0146-8693},
   url = {http://dx.doi.org/10.1093/jpepsy/jsp044},
   Abstract = {OBJECTIVE: To investigate the methylphenidate (MPH) response
             rate among childhood survivors of acute lymphoblastic
             leukemia (ALL) and brain tumors (BTs) and to identify
             predictors of positive MPH response. METHODS: Cancer
             survivors (N = 106; BT = 51 and ALL = 55) identified as
             having attention deficits and learning problems participated
             in a 3-week, double-blind, crossover trial consisting of
             placebo, low-dose MPH (0.3 mg/kg), and moderate-dose MPH
             (0.6 mg/kg). Weekly teacher and parent reports on the
             Conners' Rating Scales were gathered. RESULTS: Following
             moderate MPH dose, 45.28% of the sample was classified as
             responders. Findings revealed that more problems endorsed
             prior to the medication trial on parent and teacher ratings
             were predictive of positive medication response (p < .05).
             CONCLUSIONS: MPH significantly reduces attention problems in
             a subset of childhood cancer survivors. Parent and teacher
             ratings may assist in identifying children most likely to
             respond to MPH so prescribing may be optimally
             targeted.},
   Doi = {10.1093/jpepsy/jsp044},
   Key = {fds271082}
}

@article{fds271081,
   Author = {Bonner, MJ},
   Title = {Health related quality of life in sickle cell disease: just
             scratching the surface.},
   Journal = {Pediatr Blood Cancer},
   Volume = {54},
   Number = {1},
   Pages = {1-2},
   Year = {2010},
   Month = {January},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19785024},
   Doi = {10.1002/pbc.22301},
   Key = {fds271081}
}

@article{fds271083,
   Author = {Hardy, KK and Willard, VW and Watral, MA and Bonner,
             MJ},
   Title = {Perceived social competency in children with brain tumors:
             comparison between children on and off therapy.},
   Journal = {J Pediatr Oncol Nurs},
   Volume = {27},
   Number = {3},
   Pages = {156-163},
   Year = {2010},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/20147514},
   Abstract = {Children with brain tumors are at risk for a number of
             cognitive, academic, and social difficulties as a
             consequence of their illness and its treatment. Of these,
             the least is known about social functioning, particularly
             over the course of the illness. Thirty children with brain
             tumors were evaluated using neurocognitive and psychological
             measures, including a measure of perceived competency.
             Results indicated that off-therapy brain tumor patients
             reported more concerns about their social competence than
             both a normative sample and children on treatment. Findings
             highlight the need for more research aimed at helping
             survivors cope with long-term stressors associated with
             their illness.},
   Doi = {10.1177/1043454209357918},
   Key = {fds271083}
}

@article{fds271078,
   Author = {Willard, VW and Hardy, KK and Bonner, MJ},
   Title = {Gender differences in facial expression recognition in
             survivors of pediatric brain tumors.},
   Journal = {Psychooncology},
   Volume = {18},
   Number = {8},
   Pages = {893-897},
   Year = {2009},
   Month = {August},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19061181},
   Abstract = {OBJECTIVE: To examine the relation between gender, history
             of cranial radiation therapy (CRT) and facial expression
             recognition (FER) skill in survivors of pediatric brain
             tumors. METHODS: Fifty-three survivors (27 females)
             completed a measure of FER and an intelligence test.
             RESULTS: There was a significant interaction between gender
             and CRT on ability to interpret low-intensity facial
             expressions, such that females who had not had CRT made
             fewer errors than either females who had CRT or males.
             CONCLUSION: A history of CRT has a notable effect on FER
             skill in females: girls who received CRT performed
             significantly more poorly than girls who did
             not.},
   Doi = {10.1002/pon.1502},
   Key = {fds271078}
}

@article{fds271077,
   Author = {Hutchinson, KC and Willard, VW and Hardy, KK and Bonner,
             MJ},
   Title = {Adjustment of caregivers of pediatric patients with brain
             tumors: a cross-sectional analysis.},
   Journal = {Psychooncology},
   Volume = {18},
   Number = {5},
   Pages = {515-523},
   Year = {2009},
   Month = {May},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/18756585},
   Abstract = {OBJECTIVE: The purpose of the study was to compare the
             psychological adjustment of caregivers of children with
             brain tumors who are on-treatment with caregivers of
             children who are off-treatment. METHODS: Data were collected
             from 90 participants: 47 (52.2%) caregivers of children
             undergoing active treatment (on-treatment) and 43 (47.8%)
             caregivers of children off-treatment on measures of global
             psychological distress and illness and caregiving related
             distress. RESULTS: Results revealed that the two groups
             differed significantly in their reported symptoms of general
             psychological distress, with the off-treatment caregivers
             reporting significantly lower levels of general distress.
             However, off-treatment caregivers continued to experience
             elevated levels of uncertainty and caregiving burden related
             to their child's illness. CONCLUSIONS: There is significant
             evidence suggesting that the burden of caring for a child
             with a brain tumor is ongoing, continuing well into the
             off-treatment period. These results also suggest that the
             psychosocial functioning of these caregivers is best
             assessed using measures designed specifically to evaluate
             illness-related psychosocial functioning (e.g. the Parent
             Experience of Child Illness, Impact on Family
             Scale).},
   Doi = {10.1002/pon.1421},
   Key = {fds271077}
}

@article{fds271080,
   Author = {Thornburg, CD and Dixon, N and Burgett, S and Mortier, NA and Schultz,
             WH and Zimmerman, SA and Bonner, M and Hardy, KK and Calatroni, A and Ware,
             RE},
   Title = {A pilot study of hydroxyurea to prevent chronic organ damage
             in young children with sickle cell anemia.},
   Journal = {Pediatr Blood Cancer},
   Volume = {52},
   Number = {5},
   Pages = {609-615},
   Year = {2009},
   Month = {May},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19061213},
   Abstract = {BACKGROUND: Hydroxyurea improves laboratory parameters and
             prevents acute clinical complications of sickle cell anemia
             (SCA) in children and adults, but its effects on organ
             function remain incompletely defined. METHODS: To assess the
             safety and efficacy of hydroxyurea in young children with
             SCA and to prospectively assess kidney and brain function,
             14 young children (mean age 35 months) received hydroxyurea
             at a mean maximum tolerated dose (MTD) of 28 mg/kg/day.
             RESULTS: After a mean of 25 months, expected laboratory
             effects included significant increases in hemoglobin, MCV
             and %HbF along with significant decreases in reticulocytes,
             absolute neutrophil count, and bilirubin. There was no
             significant increase in glomerular filtration rate by DTPA
             clearance or Schwartz estimate. Mean transcranial Doppler
             (TCD) velocity changes were -25.6 cm/sec (P < 0.01) and
             -26.8 cm/sec (P < 0.05) in the right and left MCA vessels,
             respectively. At study exit, no child had conditional or
             abnormal TCD values, and none developed brain ischemic
             lesions or vasculopathy progression by MRI/MRA. Growth and
             neurocognitive scores were preserved and Impact-on-Family
             scores improved. CONCLUSIONS: These pilot data indicate
             hydroxyurea at MTD is well-tolerated by both children and
             families, and may prevent chronic organ damage in young
             children with SCA.},
   Doi = {10.1002/pbc.21738},
   Key = {fds271080}
}

@article{fds271076,
   Author = {Bonner, MJ and Hardy, KK and Willard, VW and Gururangan,
             S},
   Title = {Additional evidence of a nonverbal learning disability in
             survivors of pediatric brain tumors},
   Journal = {Children's Health Care},
   Volume = {38},
   Number = {1},
   Pages = {49-63},
   Publisher = {Informa UK Limited},
   Year = {2009},
   Month = {January},
   ISSN = {0273-9615},
   url = {http://dx.doi.org/10.1080/02739610802615849},
   Abstract = {The purpose of the study was to further examine the utility
             of the nonverbal learning disability (NLD) model for
             characterizing deficits in pediatric brain tumor survivors.
             Data from measures of cognitive, academic, and social
             functioning were gathered from 101 survivors. Results
             revealed a pattern consistent with expectations based on the
             NLD model including stronger verbal than nonverbal
             intellectual and memory functioning, stronger reading than
             math skills, and weaknesses in visual-motor integration and
             processing speed. Moreover, findings support evidence of
             social problems in this sample. Further testing of the NLD
             model is needed to provide a comprehensive roadmap for
             assessment and intervention in pediatric cancer survivors.
             Copyright © Taylor & Francis Group, LLC.},
   Doi = {10.1080/02739610802615849},
   Key = {fds271076}
}

@article{fds271079,
   Author = {Willard, VW and Bonner, MJ and Guill, AB},
   Title = {Healthy lifestyle choices after cancer treatment.},
   Journal = {Cancer Treat Res},
   Volume = {150},
   Pages = {343-352},
   Year = {2009},
   ISSN = {0927-3042},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19834679},
   Doi = {10.1007/b109924_22},
   Key = {fds271079}
}

@article{fds271075,
   Author = {Hardy, KK and Bonner, MJ and Willard, VW and Watral, MA and Gururangan,
             S},
   Title = {Hydrocephalus as a possible additional contributor to
             cognitive outcome in survivors of pediatric
             medulloblastoma.},
   Journal = {Psychooncology},
   Volume = {17},
   Number = {11},
   Pages = {1157-1161},
   Year = {2008},
   Month = {November},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/18636431},
   Abstract = {OBJECTIVES: The purpose of the study was to assess the
             relationship between shunted hydrocephalus and intellectual,
             memory and academic functioning in a group of survivors of
             pediatric medulloblastoma. METHODS: Data from measures of
             cognitive, memory, academic and visual-motor functioning
             were gathered retrospectively from 35 survivors. Of these
             survivors, 10 (28.6%) required ventriculoperitoneal-shunt
             placement for hydrocephalus posttumor resection. RESULTS:
             Results revealed that participants with shunted
             hydrocephalus demonstrated significantly lower IQs, lower
             nonverbal intellectual functioning, lower academic skills in
             writing and math, and impairments in visual-motor abilities
             when compared with those without shunt. CONCLUSIONS: These
             results highlight the need to explore other variables--in
             addition to radiation and chemotherapy--as risk factors for
             neurocognitive impairments in survivors. Furthermore,
             identification of physiological substrates underlying these
             deficits is needed.},
   Doi = {10.1002/pon.1349},
   Key = {fds271075}
}

@article{fds271099,
   Author = {Bonner, MJ and Hardy, KK and Willard, VW and Hutchinson, KC and Guill,
             AB},
   Title = {Further validation of the parent experience of child illness
             scale},
   Journal = {Children's Health Care},
   Volume = {37},
   Number = {2},
   Pages = {145-157},
   Publisher = {Informa UK Limited},
   Year = {2008},
   Month = {April},
   ISSN = {0273-9615},
   url = {http://dx.doi.org/10.1080/02739610802006569},
   Abstract = {The objective of this research is to provide further
             validation of the Parent Experience of Child Illness (PECI)
             scale. One hundred twenty-five caregivers of patients (age <
             1-17 years) diagnosed with cancer returned questionnaire
             data at Time 1, and 75 caregivers at Time 2. Findings
             provide support for the psychometric properties of the PECI,
             including good test-retest reliability and convergent and
             discriminant validity. The PECI appears to be a valid
             assessment tool for evaluation of the distress and perceived
             resources of caregivers of pediatric cancer patients.
             Continued evaluation is needed with other chronic illness
             groups. Copyright © Taylor & Francis Group,
             LLC.},
   Doi = {10.1080/02739610802006569},
   Key = {fds271099}
}

@article{fds271109,
   Author = {Hardy, KK and Bonner, MJ and Masi, R and Hutchinson, KC and Willard, VW and Rosoff, PM},
   Title = {Psychosocial functioning in parents of adult survivors of
             childhood cancer.},
   Journal = {J Pediatr Hematol Oncol},
   Volume = {30},
   Number = {2},
   Pages = {153-159},
   Year = {2008},
   Month = {February},
   ISSN = {1077-4114},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/18376269},
   Abstract = {BACKGROUND: Although significant progress has been made in
             identifying long-term sequelae for adult survivors of
             childhood cancer, comparatively little attention has been
             paid to the functioning of their parents. In a previous
             study, we observed that a majority of adult survivors are
             accompanied to clinic visits by at least 1 parent,
             suggesting ongoing concern for their children's health. In
             the current study, we explore psychologic stressors that
             characterize this population and might account for this
             finding. PROCEDURE: Responses to measures of psychosocial
             functioning (ie, Brief Symptom Inventory, Impact on Family
             Scale, Impact of Events Scale, Parent Experience of Child
             Illness Scale) were compared between 27 parents of adult
             survivors (mean age=25.6 y) of pediatric cancer and 28
             parents of current pediatric cancer patients (mean age=10.2
             y) on, or within 1 year of, active treatment. RESULTS:
             Compared with parents of pediatric cancer patients on
             treatment, parents of adult survivors demonstrated few
             significant differences in overall psychologic functioning,
             posttraumatic stress symptoms, and adjustment to the disease
             experience. Indeed, the 2 groups differed only in their
             report of objective and family burden (eg, financial cost,
             time off from work, less time with family members), and in
             their levels of anger associated with the illness
             experience. CONCLUSIONS: Results suggest that parents who
             continue to accompany their adult child to clinic may remain
             psychologically vulnerable many years after the end of
             treatment, and that the impact of having a child with a
             life-threatening illness may not diminish even years into
             the child's survivorship.},
   Doi = {10.1097/MPH.0b013e31815814d9},
   Key = {fds271109}
}

@article{fds271100,
   Author = {Arroyave, WD and Clipp, EC and Miller, PE and Jones, LW and Ward, DS and Bonner, MJ and Rosoff, PM and Snyder, DC and Demark-Wahnefried,
             W},
   Title = {Childhood cancer survivors' perceived barriers to improving
             exercise and dietary behaviors.},
   Journal = {Oncol Nurs Forum},
   Volume = {35},
   Number = {1},
   Pages = {121-130},
   Year = {2008},
   Month = {January},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/18192161},
   Abstract = {PURPOSE/OBJECTIVES: To determine childhood cancer survivors'
             barriers to increasing exercise and consuming less fat and
             more fruits and vegetables, whole grains, and calcium-rich
             foods. DESIGN: Mailed survey. SETTING: Cases from a
             comprehensive cancer center. SAMPLE: Convenience sample of
             144 childhood cancer survivors aged 13-35 years identified
             through previous research. Surveys were returned by 118
             participants (82% response rate). METHODS: Descriptive
             statistics with chi-square tests were performed between
             subgroups defined by age (< 18 years and < or = 18 years)
             and diagnosis (leukemia, lymphoma, and central nervous
             system cancers). MAIN RESEARCH VARIABLES: Barriers to
             exercise, consuming less fat, and eating more fruits and
             vegetables, whole grains, and calcium-rich foods. FINDINGS:
             Proportionately more childhood cancer survivors reported
             barriers to exercise and following a low-fat diet than to
             consuming more fruits and vegetables, whole grains, and
             calcium-rich foods. Primary barriers to exercise included
             being too tired (57%), being too busy (53%), and not
             belonging to a gym (48%), whereas barriers for restricting
             high-fat foods were commercials that make high-fat foods
             look so appealing (58%) and having friends who eat a lot of
             high-fat foods (50%). Difficulty associated with ordering
             healthy foods when dining out also was a leading barrier to
             following a low-fat diet (50%), as well as eating more whole
             grains (31%), fruits and vegetables (30%), and calcium-rich
             foods (15%). CONCLUSIONS: Childhood cancer survivors report
             several barriers to exercise and consuming a low-fat diet
             with more fruits and vegetables, whole grains, and
             calcium-rich foods. IMPLICATIONS FOR NURSING: This study's
             findings may be helpful to nurses, health educators, and
             allied health professionals in developing effective
             interventions that promote healthful lifestyle change among
             childhood cancer survivors.},
   Doi = {10.1188/08.ONF.121-130},
   Key = {fds271100}
}

@article{fds271096,
   Author = {Bonner, MJ and Hardy, KK and Willard, VW and Anthony, KK and Hood, M and Gururangan, S},
   Title = {Social functioning and facial expression recognition in
             survivors of pediatric brain tumors.},
   Journal = {J Pediatr Psychol},
   Volume = {33},
   Number = {10},
   Pages = {1142-1152},
   Year = {2008},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/18390896},
   Abstract = {OBJECTIVE: To assess social functioning and facial
             expression recognition skill in survivors of pediatric brain
             tumors (BT) as compared to children with juvenile rheumatoid
             arthritis (JRA). METHODS: The social functioning of 51
             survivors of BT and 31 children with JRA was assessed using
             a facial expression recognition task, questionnaire ratings
             of social functioning, and an IQ screener. RESULTS: After
             controlling for estimated IQ, survivors of BT made
             significantly more errors interpreting adult facial
             expressions as compared to children with JRA. Additionally,
             history of therapy and diagnosis age predicted performance
             on the child portion of the facial recognition task.
             Finally, survivors of BT demonstrated significantly impaired
             social functioning across multiple measures when compared to
             children with JRA. CONCLUSIONS: Survivors of pediatric BT
             showed significant deficits in social functioning as
             compared to an illness comparison group. Errors in facial
             expression recognition represent another method for
             evaluating deficits that contribute to social
             outcomes.},
   Doi = {10.1093/jpepsy/jsn035},
   Key = {fds271096}
}

@article{fds271095,
   Author = {Edwards, CL and Raynor, RD and Feliu, M and McDougald, C and Johnson, S and Schmechel, D and Wood, M and Bennett, GG and Saurona, P and Bonner, M and Wellington, C and DeCastro, LM and Whitworth, E and Abrams, M and Logue,
             P and Edwards, L and Martinez, S and Whitfield, KE},
   Title = {Neuropsychological assessment, neuroimaging, and
             neuropsychiatric evaluation in pediatric and adult patients
             with sickle cell disease (SCD).},
   Journal = {Neuropsychiatr Dis Treat},
   Volume = {3},
   Number = {6},
   Pages = {705-709},
   Year = {2007},
   Month = {December},
   ISSN = {1176-6328},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19300604},
   Abstract = {Traditionally, neuropsychological deficits due to Sickle
             Cell Disease (SCD) have been understudied in adults. We have
             begun to suspect, however, that symptomatic and asymptomatic
             Cerebrovascular Events (CVE) may account for an alarming
             number of deficits in this population. In the current brief
             review, we critically evaluated the pediatric and adult
             literatures on the neurocognitive effects of SCD. We
             highlighted the studies that have been published on this
             topic and posit that early detection of CVE via
             neurocognitive testing, neuropsychiatric evaluations, and
             neuroimaging may significantly reduce adult cognitive and
             functional morbidities.},
   Doi = {10.2147/ndt.s518},
   Key = {fds271095}
}

@article{fds271101,
   Author = {Conklin, HM and Khan, RB and Reddick, WE and Helton, S and Brown, R and Howard, SC and Bonner, M and Christensen, R and Wu, S and Xiong, X and Mulhern, RK},
   Title = {Acute neurocognitive response to methylphenidate among
             survivors of childhood cancer: a randomized, double-blind,
             cross-over trial.},
   Journal = {J Pediatr Psychol},
   Volume = {32},
   Number = {9},
   Pages = {1127-1139},
   Year = {2007},
   Month = {October},
   ISSN = {0146-8693},
   url = {http://dx.doi.org/10.1093/jpepsy/jsm045},
   Abstract = {OBJECTIVE: To investigate the acute efficacy and adverse
             side effects of methylphenidate (MPH) among survivors of
             childhood cancer [acute lymphoblastic leukemia (ALL) or
             brain tumor (BT)] with learning impairments. METHODS:
             Participants (N = 122) completed a two-day, in-clinic,
             double-blind, cross-over trial during which they received
             MPH (0.60 mg/kg of body weight) and placebo that were
             randomized in administration order across participants.
             Performance was evaluated using measures of attention,
             memory, and academic achievement. RESULTS: A significant MPH
             versus placebo effect was revealed on a measure of
             attention, cognitive flexibility, and processing speed
             (Stroop Word-Color Association Test). Male gender, older age
             at treatment, and higher intelligence were predictive of
             better medication response. No significant differences were
             found for number or severity of adverse side effects as a
             function of active medication. CONCLUSIONS: MPH shows some
             neurocognitive benefit and is well tolerated by the majority
             of children surviving ALL and BT.},
   Doi = {10.1093/jpepsy/jsm045},
   Key = {fds271101}
}

@article{fds271107,
   Author = {Bonner, MJ and Hardy, KK and Willard, VW and Hutchinson,
             KC},
   Title = {Brief report: psychosocial functioning of fathers as primary
             caregivers of pediatric oncology patients.},
   Journal = {J Pediatr Psychol},
   Volume = {32},
   Number = {7},
   Pages = {851-856},
   Year = {2007},
   Month = {August},
   ISSN = {0146-8693},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/17426044},
   Abstract = {OBJECTIVE: To evaluate the psychosocial functioning of
             fathers as primary caregivers of pediatric oncology
             patients. METHODS: Fathers who identified themselves as the
             primary medical caregivers were given a packet of
             questionnaires, including the Brief Symptom Inventory (BSI),
             the Impact of Event Scale (IES), the Impact on Family Scale
             (IFS), the Caregiver Strain Questionnaire (CGSQ), and the
             Parent Experience of Child Illness (PECI) scale, to complete
             and return by mail. The 23 fathers who returned the
             questionnaire packets were compared with 23 mothers who were
             matched on demographic variables. RESULTS: There were no
             differences between groups on self-report measures of
             distress or illness-related parenting stress. Descriptively,
             however, the majority of parents were above normative means
             on measures of psychological distress with a significantly
             greater proportion of fathers endorsing elevated levels of
             depression on the BSI. CONCLUSION: Including fathers in
             pediatric psychosocial research is important and represents
             a growing trend in psycho-oncology.},
   Doi = {10.1093/jpepsy/jsm011},
   Key = {fds271107}
}

@article{fds271098,
   Author = {Edwards, and CL, and Raynor, and RD, and Feliu, and M, and McDougald, and C, and Johnson, and Schmechel, and D, and Wood, and Bennett, and GG, and Saurona, and P, and Bonner, and al, MJE},
   Title = {Neuropsychological assessment, neuroimaging, and early
             neurocognitive evaluation in pediatric and adult patients
             with sickle cell disease},
   Journal = {Neuropsychiatry Disease and Treatment},
   Volume = {3},
   Pages = {1-5},
   Year = {2007},
   Key = {fds271098}
}

@article{fds304914,
   Author = {Bonner, MJ and Hardy, KK and Guill, AB and McLaughlin, C and Schweitzer,
             H and Carter, K},
   Title = {Development and validation of the parent experience of child
             illness.},
   Journal = {J Pediatr Psychol},
   Volume = {31},
   Number = {3},
   Pages = {310-321},
   Year = {2006},
   Month = {April},
   ISSN = {0146-8693},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/15917492},
   Abstract = {OBJECTIVE: To develop a measure of parent adjustment related
             to caring for a child with a chronic illness and to evaluate
             the reliability and validity of the measure with a group of
             parents of children with brain tumors. METHODS: One-hundred
             forty-nine parents of patients (age <1-17 years) diagnosed
             with a brain tumor were assessed using the 25-item
             self-report Parent Experience of Child Illness (PECI).
             Internal consistency, construct validity, and factor
             structure were assessed. RESULTS: Exploratory factor
             analysis yielded four theoretically coherent factors
             including: Guilt and Worry, Emotional Resources, Unresolved
             Sorrow and Anger, and Long-term Uncertainty. Internal
             reliability for the PECI scales ranged from .72 to .89,
             suggesting acceptable reliability. As evidence of construct
             validity, the PECI scales show significant, positive
             correlations with scales from established measures of parent
             adjustment. CONCLUSION: The PECI augments the current
             literature by providing a brief measure of parents'
             subjective distress and perceived Emotional Resources,
             domains that are critical but understudied in children with
             chronic illness and their caregivers.},
   Doi = {10.1093/jpepsy/jsj034},
   Key = {fds304914}
}

@article{fds304915,
   Author = {Helton, SC and Corwyn, RF and Bonner, MJ and Brown, RT and Mulhern,
             RK},
   Title = {Factor analysis and validity of the Conners Parent and
             Teacher Rating Scales in childhood cancer
             survivors.},
   Journal = {J Pediatr Psychol},
   Volume = {31},
   Number = {2},
   Pages = {200-208},
   Year = {2006},
   Month = {March},
   ISSN = {0146-8693},
   url = {http://dx.doi.org/10.1093/jpepsy/jsj010},
   Abstract = {OBJECTIVE: To examine the factor structure of the Conners
             Parent Rating Scale-Revised: Short Form (CPRS-R:S) and the
             Conners Teacher Rating Scale-Revised: Short Form (CTRS-R:S)
             in children who are long-term survivors of acute lymphocytic
             leukemia (ALL) or brain tumors (BT)and who have received
             central nervous system directed treatment. METHOD: Parents
             and teachers of 150 long-term survivors completed the
             CPRS-R:S or CTRS-R:S as part of a screening battery. The
             data were submitted to a maximum likelihood confirmatory
             factor analysis to test the construct validity of the scales
             and the forms were compared. The CPRS-R:S was also compared
             to selected subscales of the Achenbach Child Behavior
             Checklist (CBCL) for further validation. RESULTS: The
             analyses demonstrated an adequate fit of the original
             three-factor structure of the CTRS-R:S [oppositional,
             cognitive problems/inattention, hyperactivity]. The analyses
             of the CPRS-R:S suggested a less adequate fit of the
             original three-factor structure but principal components
             factor analysis yielded a three-factor solution with factors
             similar to those of Conners' original factor structure.
             Significant correlations were found between the CPRS-R:S and
             the selected subscales of the CBCL. CONCLUSIONS: These
             findings support the similar construct validity of the
             original CTRS-R:S and CPRS-R:S. Although significantly
             correlated, the CPRS-R:S and CTRS-R:S are not
             interchangeable in the assessment of survivors of childhood
             cancer.},
   Doi = {10.1093/jpepsy/jsj010},
   Key = {fds304915}
}

@article{fds271104,
   Author = {Reddick, WE and Shan, ZY and Glass, JO and Helton, S and Xiong, X and Wu,
             S and Bonner, MJ and Howard, SC and Christensen, R and Khan, RB and Pui,
             C-H and Mulhern, RK},
   Title = {Smaller white-matter volumes are associated with larger
             deficits in attention and learning among long-term survivors
             of acute lymphoblastic leukemia.},
   Journal = {Cancer},
   Volume = {106},
   Number = {4},
   Pages = {941-949},
   Year = {2006},
   Month = {February},
   url = {http://dx.doi.org/10.1002/cncr.21679},
   Abstract = {BACKGROUND: The primary objective of this study was to test
             the hypothesis that survivors of childhood acute
             lymphoblastic leukemia (ALL) have deficits in neurocognitive
             performance, and smaller white-matter volumes are associated
             with these deficits. METHODS: The patients studied included
             112 ALL survivors (84 patients who had received chemotherapy
             only, 28 patients who had received chemotherapy and
             irradiation; 63 males, 49 females; mean age +/- standard
             deviation, 4.1 yrs +/- 2.6 yrs at diagnosis; mean +/-
             standard deviation yrs since diagnosis, 6.0 +/- 3.5 yrs),
             and 33 healthy siblings who participated as a control group.
             Neurocognitive tests of attention, intelligence, and
             academic achievement were performed; and magnetic resonance
             images were obtained and subsequently were segmented to
             yield tissue volume measurements. Comparisons of
             neurocognitive measures and tissue volumes between groups
             were performed, and the correlations between volumes and
             neurocognitive performance measures were assessed. RESULTS:
             Most performance measures demonstrated statistically
             significant differences from the normative test scores, but
             only attention measures exceeded 1.0 standard deviation from
             normal. Patients who had received chemotherapy alone had
             significantly larger volumes of white matter than patients
             who had received treatment that also included cranial
             irradiation, but their volumes remained significantly
             smaller than the volumes in the control group. Smaller
             white-matter volumes were associated significantly with
             larger deficits in attention, intelligence, and academic
             achievement. CONCLUSIONS: Survivors of childhood ALL had
             significant deficits in attention and smaller white-matter
             volumes that were associated directly with impaired
             neurocognitive performance. Cranial irradiation exacerbated
             these deficits.},
   Doi = {10.1002/cncr.21679},
   Key = {fds271104}
}

@article{fds271060,
   Author = {Bonner, MJ and Hardy, KK and Willard, VW and Guill,
             AB},
   Title = {Association between the Parent Experience of Childhood
             Illness (PECI) scale and clinician ratings of functioning
             among parents of children with cancer},
   Journal = {PSYCHO-ONCOLOGY},
   Volume = {15},
   Number = {1},
   Pages = {S41-S42},
   Publisher = {JOHN WILEY & SONS LTD},
   Year = {2006},
   Month = {February},
   ISSN = {1057-9249},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235659000075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271060}
}

@article{fds271102,
   Author = {Bonner, MJ and Hardy, KK and Guill, AB and McLaughlin, C and Schweitzer,
             H and Carter, K},
   Title = {Development and validation of the ParentExperience of
             Illness (PECI) Questionnaire},
   Journal = {Journal of Pediatric Psychology},
   Volume = {31},
   Number = {3},
   Pages = {310-321},
   Year = {2006},
   ISSN = {0146-8693},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/15917492},
   Abstract = {OBJECTIVE: To develop a measure of parent adjustment related
             to caring for a child with a chronic illness and to evaluate
             the reliability and validity of the measure with a group of
             parents of children with brain tumors. METHODS: One-hundred
             forty-nine parents of patients (age <1-17 years) diagnosed
             with a brain tumor were assessed using the 25-item
             self-report Parent Experience of Child Illness (PECI).
             Internal consistency, construct validity, and factor
             structure were assessed. RESULTS: Exploratory factor
             analysis yielded four theoretically coherent factors
             including: Guilt and Worry, Emotional Resources, Unresolved
             Sorrow and Anger, and Long-term Uncertainty. Internal
             reliability for the PECI scales ranged from .72 to .89,
             suggesting acceptable reliability. As evidence of construct
             validity, the PECI scales show significant, positive
             correlations with scales from established measures of parent
             adjustment. CONCLUSION: The PECI augments the current
             literature by providing a brief measure of parents'
             subjective distress and perceived Emotional Resources,
             domains that are critical but understudied in children with
             chronic illness and their caregivers.},
   Doi = {10.1093/jpepsy/jsj034},
   Key = {fds271102}
}

@article{fds271103,
   Author = {Helton, S and Corwyn, RF and Bonner, MJ and Brown, RT and Mulhern,
             RK},
   Title = {Factor analysis and teacher rating scales in childhood
             cancer survivors},
   Journal = {Journal of Pediatric Psychology},
   Volume = {31},
   Number = {2},
   Pages = {200-208},
   Year = {2006},
   ISSN = {0146-8693},
   url = {http://dx.doi.org/10.1093/jpepsy/jsj010},
   Abstract = {Objective: To examine the factor structure of the Conners
             Parent Rating Scale - Revised: Short Form (CPRS-R:S) and the
             Conners Teacher Rating Scale - Revised: Short Form
             (CTRS-R:S) in children who are long-term survivors of acute
             lymphocytic leukemia (ALL) or brain tumors (BT)and who have
             received central nervous system directed treatment. Method:
             Parents and teachers of 150 long-term survivors completed
             the CPRS-R:S or CTRS-R:S as part of a screening battery. The
             data were submitted to a maximum likelihood confirmatory
             factor analysis to test the construct validity of the scales
             and the forms were compared. The CPRS-R:S was also compared
             to selected subscales of the Achenbach Child Behavior
             Checklist (CBCL) for further validation. Results: The
             analyses demonstrated an adequate fit of the original
             three-factor structure of the CTRS-R:S [oppositional,
             cognitive problems/inattention, hyperactivity]. The analyses
             of the CPRS-R:S suggested a less adequate fit of the
             original three-factor structure but principal components
             factor analysis yielded a three-factor solution with factors
             similar to those of Conners' original factor structure.
             Significant correlations were found between the CPRS-R:S and
             the selected subscales of the CBCL. Conclusions: These
             findings support the similar construct validity of the
             original CTRS-R:S and CPRS-R:S. Although significantly
             correlated, the CPRS-R:S and CTRS-R:S are not
             interchangeable in the assessment of survivors of childhood
             cancer. © The Author 2005. Published by Oxford University
             Press on behalf of the Society of Pediatric Psychology. All
             rights reserved.},
   Doi = {10.1093/jpepsy/jsj010},
   Key = {fds271103}
}

@article{fds271071,
   Author = {Demark-Wahnefried, W and Werner, C and Clipp, EC and Guill, AB and Bonner, M and Jones, LW and Rosoff, PM},
   Title = {Survivors of childhood cancer and their guardians.},
   Journal = {Cancer},
   Volume = {103},
   Number = {10},
   Pages = {2171-2180},
   Year = {2005},
   Month = {May},
   ISSN = {0008-543X},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/15812823},
   Abstract = {BACKGROUND: Survivors of childhood cancer are at increased
             risk for osteoporosis, cardiovascular disease, and second
             malignancies-conditions for which modifiable risk factors
             are recognized and lifestyle interventions have shown
             benefit. Although some data regarding health behaviors of
             this population exist, receptivity to health promotion is
             largely unknown. METHODS: A survey was mailed to 380
             survivors (age range, 11-33 years) of childhood leukemia,
             lymphoma, or central nervous system carcinomas (and
             guardians of survivors < 18 years old) to elicit data on
             exercise, dietary intake of calcium, fat, and fruits and
             vegetables, smoking status, readiness to pursue lifestyle
             change, quality of life, and interest in various health
             interventions. RESULTS: Responses from 209 survivors (a 55%
             response rate) suggested that most did not meet guidelines
             for fruit and vegetable consumption (79%), calcium intake
             (68%), or exercise (52%), 42% were overweight/obese, and 84%
             consumed > 30% of calories from fat. Older (> 18 years)
             compared with younger (< 18 years) survivors were more
             likely to smoke (17% vs. 1%), to be obese (21.6% vs. 14.6%),
             and to have suboptimal calcium intakes (75.6% vs. 57.6%). No
             differences in lifestyle behaviors were observed between
             cancer groups. Compared with interventions aimed at weight
             control, improving self-esteem, or smoking cessation, the
             highest levels of interest were found consistently for
             interventions aimed at getting in shape and eating healthy.
             Survivors preferred mailed interventions to those delivered
             in-person, by telephone counselors, or via computers.
             CONCLUSIONS: Survivors of childhood cancer practiced several
             suboptimal health behaviors. Health promotion interventions
             aimed at areas of interest and delivered through acceptable
             channels have the potential to improve long-term health and
             function of this vulnerable population.},
   Doi = {10.1002/cncr.21009},
   Key = {fds271071}
}

@article{fds271072,
   Author = {Rosoff, PM and Werner, C and Clipp, EC and Guill, AB and Bonner, M and Demark-Wahnefried, W},
   Title = {Response rates to a mailed survey targeting childhood cancer
             survivors: a comparison of conditional versus unconditional
             incentives.},
   Journal = {Cancer Epidemiol Biomarkers Prev},
   Volume = {14},
   Number = {5},
   Pages = {1330-1332},
   Year = {2005},
   Month = {May},
   ISSN = {1055-9965},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/15894697},
   Abstract = {OBJECTIVE: Mailed surveys are widely used to collect
             epidemiologic and health service data. Given that
             nonresponse can threaten the validity of surveys, modest
             incentives are often used to increase response rates. A
             study was undertaken among childhood cancer survivors and
             their parents to determine if response rate to a mailed
             survey differed with provision of immediate versus delayed
             incentives. DESIGN: A self-administered survey designed to
             ascertain health behaviors was mailed to 397 childhood
             cancer survivors (and their parents if the survivor was <18
             years of age). Subjects were randomized into two groups
             based on gender, age, race, and cancer type. One group
             received a 10 US dollars incentive with their blank survey
             (unconditional incentive), whereas the other group received
             the incentive upon receipt of their completed survey
             (conditional incentive). If children were minors, both the
             parent and the child received incentives. RESULTS: No
             significant differences in response rates were observed with
             respect to gender, age, race, or cancer type. However,
             significant differences in response rates were observed
             between incentive groups, with unconditional incentives
             yielding significantly higher response rates than
             conditional incentives for child survivors who were > or =18
             years (64.4% versus 49.0%), as well as younger child
             survivors (62.5% versus 43.6%) and their parents (64.8%
             versus 41.5%; all P < 0.05). CONCLUSIONS: The provision of
             an immediate incentive generated significantly higher
             response rates to this mailed health survey among childhood
             cancer survivors and their parents. Given that survey
             studies are commonly conducted across various pediatric
             populations, these findings may help inform the design of
             future pediatric survey research.},
   Doi = {10.1158/1055-9965.EPI-04-0716},
   Key = {fds271072}
}

@article{fds271105,
   Author = {Demark Wahnefried and W and Werner, C and Clipp, E and Guill, AB and Bonner, MJ and Rosoff, PM},
   Title = {Childhood cander survivors and their guardians: Current
             health behaviors and receptivity to health promotion
             programs},
   Journal = {Cancer},
   Volume = {103},
   Year = {2005},
   Key = {fds271105}
}

@article{fds271106,
   Author = {Rosoff, PM and Werner, C and Clipp, E and Guill, AB and Bonner, MJ and Demark Wahnefried and W},
   Title = {Response rates to a mailed survey targeting childhood cancer
             survivors},
   Journal = {Cancer Epidemiology, Biomarkers and Prevention},
   Volume = {14},
   Pages = {1330-1332},
   Year = {2005},
   Key = {fds271106}
}

@article{fds271108,
   Author = {Mulhern, RK and Khan, RB and Kaplan, S and Helton, S and Christensen, R and Bonner, M and Brown, R and Xiong, X and Wu, S and Gururangan, S and Reddick, WE},
   Title = {Short-term efficacy of methylphenidate: a randomized,
             double-blind, placebo-controlled trial among survivors of
             childhood cancer.},
   Journal = {Journal of clinical oncology : official journal of the
             American Society of Clinical Oncology},
   Volume = {22},
   Number = {23},
   Pages = {4795-4803},
   Year = {2004},
   Month = {December},
   ISSN = {0732-183X},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/15570081},
   Abstract = {PURPOSE: Children surviving acute lymphoblastic leukemia
             (ALL) and malignant brain tumors (BTs) have a higher
             incidence of attention and learning problems in school than
             do their healthy peers. The present study tests the
             hypothesis that the psychostimulant methylphenidate (MPH)
             improves cognitive and social functioning among these
             patients. PATIENTS AND METHODS: We report on 83 long-term
             survivors of ALL and BT identified as having attentional
             deficits on behavioral testing and parent or teacher report,
             and problems with academic achievement. The 47 male and 36
             female patients ranged from 0.6 to 14.3 years (median, 5.4
             years) of age at diagnosis and 6.7 to 17.9 years (median,
             11.9 years) of age at participation. The patients (40 ALL,
             43 BT) participated in a randomized, double-blind, 3-week
             home cross-over trial of placebo (bid), low-dose MPH (0.3
             mg/kg; maximum dose, 10 mg bid), and moderate-dose MPH (0.6
             mg/kg; maximum dose, 20 mg bid). The primary end points were
             weekly teacher and parent reports on the Conners' Rating
             Scales and Social Skills Rating System. RESULTS: Compared to
             placebo, significant improvement with MPH was reported by
             teachers and parents on the Conners' Rating Scales and by
             teachers on the Social Skills Rating System. However, no
             consistent advantage of moderate dose over low dose was
             observed. Of those participating, 66 (79.5%) of the 83
             patients continued on best clinical management. CONCLUSION:
             Treatment with MPH can at least temporarily reduce some
             attentional and social deficits among survivors of childhood
             ALL and BT. Long-term follow-up will reveal those subsets of
             patients who are more likely to benefit from
             MPH.},
   Doi = {10.1200/JCO.2004.04.128},
   Key = {fds271108}
}

@article{fds271114,
   Author = {Thompson, RJ and Gustafson, KE and Bonner, MJ and Ware,
             RE},
   Title = {Neurocognitive development of young children with sickle
             cell disease through three years of age.},
   Journal = {J Pediatr Psychol},
   Volume = {27},
   Number = {3},
   Pages = {235-244},
   Year = {2002},
   ISSN = {0146-8693},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/11909931},
   Keywords = {Anemia, Sickle Cell • Child, Preschool • Cognition
             Disorders • Female • Follow-Up Studies •
             Helplessness, Learned • Hemoglobin SC Disease •
             Hemoglobin, Sickle • Humans • Infant •
             Infant, Newborn • Intelligence • Internal-External
             Control • Male • Neuropsychological Tests* •
             Parenting • Phenotype • Psychomotor Disorders
             • Risk Factors • diagnosis • genetics •
             psychology • psychology*},
   Abstract = {OBJECTIVE: To determine (1) the neurocognitive development
             of children with sickle cell disease (SCD) from 6 months
             through 36 months of age, (2) the independent and combined
             contributions of biomedical risk and parenting risk to child
             neurocognitive functioning, and (3) the independent and
             combined contributions of biomedical risk, parent cognitive
             processes, and family functioning to parent adjustment.
             METHOD: The study sample included 89 African American
             children and their parents served through the Duke
             University-University of North Carolina Comprehensive Sickle
             Cell Center. Measures of cognitive and psychomotor
             development were obtained at 6, 12, 24, and 36 months of
             age, and parents completed self-report measures of the
             cognitive processes of daily stress and attributional style,
             psychological adjustment, and family functioning. RESULTS:
             There was no significant decrease in psychomotor functioning
             (PDI) over time but cognitive functioning (MDI) declined,
             with a significant decrease occurring between the 12- and
             24-month assessment points. At 24 months, poorer cognitive
             functioning was associated with parenting risk, in terms of
             a learned-helplessness attributional style, and biomedical
             risk, in terms of HbSS phenotype. Levels of psychological
             distress within the clinical range were reported by 24% of
             the parents, and poorer parent adjustment was associated
             with high levels of daily stress, less knowledge about child
             development, lower expectations of efficacy, and HbSC
             phenotype. CONCLUSIONS: The findings indicate that young
             children with SCD are at risk for neurocognitive impairment
             and provide support for the initiation of early intervention
             studies to promote neurocognitive development.},
   Doi = {10.1093/jpepsy/27.3.235},
   Key = {fds271114}
}

@article{fds271113,
   Author = {Bonner, MJ and Schumacher, E and Gustafson, KE and Thompson,
             RJ},
   Title = {The impact of sickle cell disease on cognitive functioning
             and learning},
   Journal = {School Psychology Review},
   Volume = {28},
   Number = {2},
   Pages = {182-193},
   Year = {1999},
   Month = {December},
   Abstract = {Sickle Cell Disease (SCD) refers to a complex group of
             hereditary hematologic disorders that are most common in
             people of African descent (Sickle Cell Disease Guideline
             Panel, 1993). Although most children with SCD demonstrate
             adequate academic functioning, some children experience
             neurological insults such as strokes that can negatively
             affect school performance. Even in the absence of overt
             neurological disease, SCD puts some children at risk for
             neuropsychological sequelae including lowered intellectual
             functioning, academic skills deficits, impaired fine-motor
             functioning, and attentional deficits. Studies that document
             these deficits have evolved from descriptive summaries to
             more methodologically sound investigations of
             neuropsychological deficits with corresponding
             neuroradiographic findings. These studies will be reviewed
             to highlight the sometimes subtle and complex
             neuropsychological impairments found in some children with
             SCD. This review also will demonstrate the importance of
             careful monitoring and assessment of all children with SCD
             to facilitate early identification of that subset of
             children with neuropsychological sequelae. Additionally,
             possible indirect effects of SCD that can negatively impact
             school performance will be highlighted including
             absenteeism, psychological functioning, and pain coping.
             Finally, recommendations for school programming are offered
             to facilitate an optimal learning environment for school
             children with SCD.},
   Key = {fds271113}
}

@article{fds271112,
   Author = {Putnam, DE and Finney, JW and Barkley, PL and Bonner,
             MJ},
   Title = {Enhancing commitment improves adherence to a medical
             regimen.},
   Journal = {J Consult Clin Psychol},
   Volume = {62},
   Number = {1},
   Pages = {191-194},
   Year = {1994},
   Month = {February},
   ISSN = {0022-006X},
   url = {http://dx.doi.org/10.1037//0022-006x.62.1.191},
   Abstract = {A commitment-based intervention was evaluated for
             improvement of adherence to a 10-day antibiotic regimen.
             Experimental Ss made verbal and written commitments for
             adherence and completed tasks designed to increase their
             investment in a medication regimen. Control Ss performed
             similarly structured tasks unrelated to the medical regimen.
             Adherence, measured by unannounced pill counts, was
             significantly higher for experimental subjects than for
             control Ss. Self-reported adherence was significantly
             correlated with posttest self-efficacy but not with pretest
             self-efficacy. Adherence to a medical regimen may be
             improved by strategies conceptually based on the investment
             model of commitment, which provides a useful framework for
             further study of adherence.},
   Doi = {10.1037//0022-006x.62.1.191},
   Key = {fds271112}
}

@article{fds271069,
   Author = {Finney, JW and Bonner, MJ},
   Title = {The Influence of Behavioural Family Intervention on the
             Health of Chronically Ill Children},
   Journal = {Behaviour Change},
   Volume = {9},
   Number = {3},
   Pages = {157-170},
   Publisher = {Cambridge University Press (CUP)},
   Year = {1992},
   Month = {January},
   url = {http://dx.doi.org/10.1017/S0813483900006306},
   Abstract = {Chronic illnesses in children and adolescents present
             difficulties for the individual and family. A family systems
             perspective can provide directions for assessment and
             intervention with these children and their families. A
             review is made of research on family interventions for
             children with juvenile rheumatoid arthritis, cancer, and
             insulin-dependent diabetes mellitus (IDDM), and the
             influence of intervention on health outcomes is discussed.
             Few family interventions, particularly behavioural family
             interventions, have been rigorously evaluated, but
             multisystemic models show promise for improving children's
             health outcomes and family adaptation to chronic illnesses.
             © 1992, Cambridge University Press. All rights
             reserved.},
   Doi = {10.1017/S0813483900006306},
   Key = {fds271069}
}

@article{fds271111,
   Author = {Finney, JW and Bonner, MJ},
   Title = {The influence of behavioral family intervention on
             children's health and health care use},
   Journal = {Behavior Change},
   Volume = {9},
   Pages = {157-170},
   Year = {1992},
   Key = {fds271111}
}

@article{fds271110,
   Author = {Edwards, MC and Finney, JW and Bonner, M},
   Title = {Matching treatment with recurrent abdominal pain symptoms:
             An evaluation of dietary fiber and relaxation
             treatments},
   Journal = {Behavior Therapy},
   Volume = {22},
   Number = {2},
   Pages = {257-267},
   Year = {1991},
   Month = {January},
   ISSN = {0005-7894},
   url = {http://dx.doi.org/10.1016/S0005-7894(05)80181-9},
   Abstract = {We evaluated whether symptoms of recurrent abdominal pain in
             children provide a basis for treatment selection. Subjects
             were assigned to dietary fiber or relaxation treatments
             based upon whether they presented with symptoms of
             constipation. Elven subjects were treated in a combined
             multiple baseline and A-B or A-B-C design. As a control,
             some subjects recived the alternative treatment first. All
             four subjects with symptoms of constipation showed
             reductions in the number of stomachaches during the dietary
             fiber treatment. Of the seven subjects without symptoms of
             constipation, one showed reductions in stomachaches during
             the relaxation treatment, three showed some minimal
             reduction that was difficult to attribute to the relaxation
             treatment, two responded to the dietary fiber treatment, and
             one spontaneously improved during baseline. Results support
             the effectiveness of a dietary fiber treatment for children
             with symptoms of constipation. Minimal support was obtained
             for the effectiveness of a relaxation treatment for children
             without symptoms of constipation. Implications, limitations,
             and directions for future research are discussed. © 1991
             Association for Advancement of Behavior Therapy. All right
             reserved.},
   Doi = {10.1016/S0005-7894(05)80181-9},
   Key = {fds271110}
}


%% Chapters in Books   
@misc{fds312977,
   Author = {Ware, RE and Davis, BR and Schultz, WH and Brown, C and Aygun, B and Sarnaik, SA and Odame, I and Fuh, B and George, A and Owen, W and Luchtman-Jones, L and Rogers, ZR and Hilliard, L and Gauger, C and Piccone, CM and Lee, MT and Kwiatkowski, J and Jackson, S and Miller,
             ST and Roberts, CW and Heeney, MM and Kalfa, TA and Nelson, SC and Imran,
             H and Nottage, KA and Alvarez, OA and Rhodes, M and Thompson, AA and Rothman, J and Helton, KJ and Roberts, D and Coleman, J and Bonner, MJ and Kutlar, A and Patel, N and Wood, JC and Piller, L and Wei, P and Luden, J and Mortier, NA and Stuber, S and Luban, NLC and Cohen, AR and Pressel, SL and Adams, RJ},
   Title = {TCD with Transfusions Changing to Hydroxyurea (TWiTCH):
             Hydroxyurea Therapy As an Alternative to Transfusions for
             Primary Stroke Prevention in Children with Sickle Cell
             Anemia},
   Journal = {BLOOD},
   Volume = {126},
   Number = {23},
   Pages = {3 pages},
   Publisher = {AMER SOC HEMATOLOGY},
   Year = {2015},
   Month = {December},
   ISSN = {0006-4971},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368019000067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds312977}
}

@misc{fds271058,
   Author = {Willard, VW and Hardy, KK and Allen, TM and Hwang, EI and Gururangan, S and Hostetter, SA and Bonner, MJ},
   Title = {Sluggish cognitive tempo in survivors of pediatric brain
             tumors.},
   Journal = {J Neurooncol},
   Volume = {114},
   Number = {1},
   Pages = {71-78},
   Year = {2013},
   Month = {August},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270494800354&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Abstract = {The presence of neurocognitive late effects in survivors of
             pediatric brain tumors is well established. However, there
             remains some debate about how best to conceptualize these
             deficits. Sluggish cognitive tempo (SCT) is a proposed
             conceptual framework that has been used to describe a subset
             of children with ADHD who exhibit a particular profile
             characterized by lethargy, day dreaming and staring, and
             poor organization. Previous work has suggested that
             survivors of leukemia exhibit a similar profile, but it has
             not yet been examined in survivors of pediatric brain
             tumors. A sample of 65 survivors of pediatric brain tumors,
             25 survivors of leukemia and 50 community controls completed
             the Child Behavior Checklist, with four items used to
             measure SCT. Survivors completed additional measures of
             neurocognitive functioning. Survivors of brain tumors
             demonstrated significantly greater symptoms of SCT than
             survivors of leukemia or controls. SCT was associated with
             attention problems and working memory deficits and the
             presence of a VP-shunt. Results provided conditional support
             for the presence of SCT in survivors of brain tumors, with
             further research needed to determine the clinical utility of
             the framework.},
   Doi = {10.1007/s11060-013-1149-8},
   Key = {fds271058}
}

@misc{fds271064,
   Author = {Palmer, SL and Lesh, S and Wallace, D and Bonner, MJ and Swain, M and Chapieski, L and Mabbott, DJ and Knight, S and Boyle, R and Armstrong,
             C and Gajjar, A},
   Title = {HOW DO PARENTS COPE WITH THEIR CHILD'S DIAGNOSIS AND
             TREATMENT OF AN EMBRYONAL TUMOR? RESULTS OF A PROSPECTIVE
             AND LONGITUDINAL STUDY},
   Journal = {NEURO-ONCOLOGY},
   Volume = {12},
   Number = {6},
   Pages = {II16-II16},
   Publisher = {OXFORD UNIV PRESS INC},
   Year = {2010},
   Month = {June},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000278817700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271064}
}

@misc{fds271066,
   Author = {Thornburg, CD and Dixon, N and Burgett, S and Mortier, NA and Zimmerman,
             SA and Bonner, MJ and Calatroni, A and Ware, RE},
   Title = {Efficacy of Hydroxyurea To Prevent Organ Damage in Young
             Children with Sickle Cell Anemia.},
   Journal = {Blood},
   Volume = {110},
   Number = {11},
   Pages = {3386-3386},
   Publisher = {American Society of Hematology},
   Year = {2007},
   Month = {November},
   ISSN = {0006-4971},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000251100804423&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Abstract = {<jats:title>Abstract</jats:title> <jats:p>Hydroxyurea (HU)
             prevents many acute complications of sickle cell anemia
             (SCA) in adults and children, but its potential to delay or
             prevent chronic organ damage has not been defined. The
             objectives of this prospective IRB-approved study were to
             assess the safety and efficacy of HU in young children with
             SCA (age 18 mon–5 years) and to determine whether 2 years
             of therapy preserves renal function, reduces transcranial
             doppler ultrasound (TCD) values, and prevents development of
             brain ischemia as evidenced by magnetic resonance
             imaging/angiography (MRI/MRA). Fourteen children with SCA
             (11 male, 3 female; mean age 35±11 mon) enrolled and
             underwent evaluation including blood counts, %HbF
             measurement, determination of the glomerular filtration rate
             (GFR) by radionuclide DTPA clearance and Schwartz estimate,
             TCD mean cerebral artery (MCA) velocities, and brain
             MRI/MRA. HU was started at 20 mg/kg/day and escalated by
             5mg/kg/day every 8 weeks to a maximum tolerated dose (MTD)
             or 30 mg/kg/day (mean dose 28±4 mg/kg). Children were
             evaluated initially every 4 weeks. All baseline tests were
             repeated at study exit (mean time 25±3 months). HU was
             tolerated well by all children. Hematological changes
             occurred as expected, with significant increases observed in
             hemoglobin concentration, MCV, and %HbF and significant
             decreases in reticulocytes, WBC, and neutrophils. The
             average GFR value did not rise as expected in this age
             range; the DTPA GFR decreased by 5.1 mL/min/1.73 m2 (p=0.26)
             with only 3 of 11 exit studies exceeding 150 mL/min/1.73 m2
             and the Schwartz estimate increased by 16.5 mL/min/1.73 m2
             (p=0.17). During HU therapy, the average TCD values
             significantly decreased with a mean decrease of 26±28
             cm/sec in the right MCA (p&lt;.01) and mean decrease of
             27±33 in the left MCA (p&lt;.05). At study entry, 3
             children had conditional TCD velocities, but all were normal
             at study exit. One child had mild small vessel ischemic
             changes on MRI at study entry that were unchanged at study
             exit. Two children had mild MRA changes that were stable or
             improved at the end of the study. All children had normal or
             improved rates of growth and development during therapy. Two
             children required PRBC transfusion for acute events (acute
             chest syndrome and hypoplastic anemia during a viral
             illness). There was one episode of Moraxella catarrhalis
             bacteremia that was unrelated to myelosuppression and
             responded to antibiotic therapy. One child was removed from
             study at week 82 due to the development of thrombocytopenia
             and hypersplenism, another had acute splenic sequestration
             but continued HU without recurrence, and a third child with
             previous acute splenic sequestration did not have recurrence
             during the study. In conclusion, HU therapy appears to be
             well tolerated in young children with SCA. In addition to
             providing beneficial changes in hematological parameters, HU
             has salutary effects on both the kidney and brain. HU
             therapy was associated with a stable GFR value during a time
             interval when hyperfiltration develops, and led to
             significant decreases in TCD velocities. However,
             preservation of splenic tissue could lead to an increased
             risk of splenic complications. Follow-up studies are
             warranted to determine if long-term HU therapy can preserve
             or restore organ function in this patient
             population.</jats:p>},
   Doi = {10.1182/blood.v110.11.3386.3386},
   Key = {fds271066}
}

@misc{fds271059,
   Author = {Hardy, KK and Bonner, MJ and Willard, VW and Hutchinson,
             KC},
   Title = {Parent and family psychosocial adjustment as a function of
             pediatric tumor type},
   Journal = {NEURO-ONCOLOGY},
   Volume = {8},
   Number = {4},
   Pages = {479-479},
   Publisher = {DUKE UNIV PRESS},
   Year = {2006},
   Month = {October},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240877301339&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271059}
}

@misc{fds271062,
   Author = {Hardy, KK and Bonner, MJ and Willard, VW},
   Title = {Hydrocephalus as an additional risk factor for academic and
             intellectual outcome in survivors of pediatric
             medulloblastoma treated with radiation},
   Journal = {NEURO-ONCOLOGY},
   Volume = {8},
   Number = {4},
   Pages = {479-480},
   Publisher = {DUKE UNIV PRESS},
   Year = {2006},
   Month = {October},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240877301340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271062}
}

@misc{fds271065,
   Author = {Bonner, MJ and Hardy, KK and Willard, VW},
   Title = {Fatigue in adolescent survivors of pediatric
             cancer},
   Journal = {NEURO-ONCOLOGY},
   Volume = {8},
   Number = {4},
   Pages = {476-476},
   Publisher = {DUKE UNIV PRESS},
   Year = {2006},
   Month = {October},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240877301327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271065}
}

@misc{fds271068,
   Author = {Hood, MA and Anthony, KK and Bonner, MJ and Hardy, KK and Willard, VW and Schanberg, LE},
   Title = {Social and nonverbal functioning in children with juvenile
             rheumatoid arthritis (JRA).},
   Journal = {ARTHRITIS AND RHEUMATISM},
   Volume = {54},
   Number = {9},
   Pages = {S506-S506},
   Publisher = {WILEY-LISS},
   Year = {2006},
   Month = {September},
   ISSN = {0004-3591},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240877202350&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271068}
}

@misc{fds271063,
   Author = {Bonner, MJ and Hardy, KK and Guill, AB and Willard, VW and Carter, KE and Gururangan, S},
   Title = {Quality of life in pediatric brain tumor
             survivors},
   Journal = {NEURO-ONCOLOGY},
   Volume = {7},
   Number = {3},
   Pages = {336-336},
   Publisher = {DUKE UNIV PRESS},
   Year = {2005},
   Month = {July},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230463900219&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271063}
}

@misc{fds271061,
   Author = {Hardy, KK and Bonner, MJ and Bromell, L and Gururangan,
             S},
   Title = {Preliminary evidence of nonverbal learning disability in
             survivors of pediatric brain tumors},
   Journal = {NEURO-ONCOLOGY},
   Volume = {6},
   Number = {4},
   Pages = {446-446},
   Publisher = {DUKE UNIV PRESS},
   Year = {2004},
   Month = {October},
   ISSN = {1522-8517},
   url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224332400511&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
   Key = {fds271061}
}

@misc{fds359832,
   Author = {Bonner, MJ and Hardy, KK and Ezell, E and Ware, R},
   Title = {Hematological disorders: Sickle cell disease and
             hemophilia},
   Pages = {241-261},
   Booktitle = {Handbook of Pediatric Psychology in School
             Settings},
   Year = {2003},
   Month = {September},
   ISBN = {9780805839173},
   Key = {fds359832}
}


Duke University * Arts & Sciences * Faculty * Staff * Grad * Postdocs * Reload * Login